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Like the other more well-characterized post-translational modiﬁcations (phosphorylation,
methylation, acetylation, acylation, etc.), the attachment of the 76 amino acid ubiquitin
(Ub) protein to substrates has been shown to govern countless cellular processes. As
obligate intracellular parasites, viruses have evolved the capability to commandeer many
host processes in order to maximize their own survival, whether it be to increase viral
production or to ensure the long-term survival of latently infected host cells.The ﬁrst evi-
dence that viruses could usurp the Ub system came from the DNA tumor viruses and
Adenoviruses, each of which use Ub to dysregulate the host cell cycle (Scheffner et al.,
1990; Querido et al., 2001).Today, the list of viruses that utilize Ub includes members from
almost every viral class, encompassing both RNA and DNA viruses. Among these, there
are examples of Ub usage at every stage of the viral life cycle, involving both ubiquitination
and de-ubiquitination. In addition to viruses that merely modify the host Ub system, many
of the large DNA viruses encode their own Ub modifying machinery. In this review, we
highlight the latest discoveries regarding the myriad ways that viruses utilize Ub to their
advantage.
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INTRODUCTION
In order to discuss the ways in which viruses exploit the host
Ub machinery, we must ﬁrst provide a general outline of that
machinery. Prior to its conjugation to targeted proteins,Ub is ﬁrst
activated via anATP-dependent thioester linkage to an E1 enzyme
(reviewed in Schulman and Harper, 2009). Once activated, the
energy in that unstable bond is then used to couple the Ub moi-
ety’s C-terminal residue to the catalytic Cys residue of an E2 Ub
conjugating enzyme (reviewed in Pickart, 2001). Ub-loaded E2
enzymes are then ready to form conjugates between the Ub C-
terminal glycine and either Lys,Ser,Thr,Cys,or N-terminal-MET
residues within proteins to be ubiquitinated (Breitschopf et al.,
1998;Cadwell and Coscoy,2005;Wang et al.,2007;Williams et al.,
2007). The speciﬁcity of that conjugation process is conferred by
the over 600 E3 Ub ligases encoded by the human genome (Li
et al., 2008). Thus far, four primary types of E3 ligases have been
described,andtheirsub-categorizationisbasedoncommonstruc-
tural features. The RING (really interesting new gene,reviewed in
Deshaies and Joazeiro, 2009) ligases, which are by far the most
commonly occurring E3s, serve as docking complexes that bring
E2 and target proteins within close proximity, whereupon the E2
catalyzes the transfer of Ub to the substrate protein. The primary
identifying feature of a RING domain is a conserved (Cys)3-His-
(Cys)4 sequence that coordinates a pair of zinc atoms to maintain
its structure. The plant homeodomain (PHD) ligases are struc-
turally related to the RING ligases and use what appears to be a
reversed set of residues [(Cys)4-His-(Cys)3] to coordinate a pair
of zinc atoms (reviewed in Bienz, 2006). PHD domains are found
in many chromatin-binding proteins, and once their similarity to
RING domains was noted, it was expected that at least a subset
of these would also function as E3s. However, thus far, only two
examplesof PHDproteinswithE3activityhavesurfaced(Duland
Walworth,2007;Ivanov et al.,2007). The U-box (ubiquitin fusion
degradation, UFD2-homology domain) ligases were ﬁrst identi-
ﬁed in yeast (Koegl et al.,1999),and seven human genes encoding
such ligases have been identiﬁed (reviewed in Marin, 2010). A
subset of this family are referred to as E4 ligases, which are dis-
tinguished from E3 ligases by virtue of their speciﬁc targeting of
substrates that have already been modiﬁed with 1–3 ubiquitin
residues (Hoppe, 2005). Interestingly, U-box ligases are struc-
turally related to RING ﬁngers,but this structure is maintained in
theabsenceof zinc-chelatingresidues(AravindandKoonin,2000;
Ohietal.,2003).Therefore,basedonstructuralfeaturesalone,the
RING, PHD, and U-box ligases can all be viewed as RING-like
variants.Finally,theHECT(homologoustoE6-associatedprotein
C-terminus, reviewed in Rotin and Kumar, 2009) ligases harbor
theirowncatalyticcysteineresiduestowhichUbisﬁrsttransferred
from an E2 enzyme. Once loaded, the HECT ligases themselves
catalyze target ubiquitination.
As initially described, lysines were the residues most fre-
quently modiﬁed via ubiquitination, and it was found that K48-
linked polyubiquitin chains were attached to proteins destined
for degradation via the 26S proteasome (reviewed in Hershko
and Ciechanover, 1998; Mayer, 2000). Since that time, it is now
appreciated that all seven Lys residues within Ub can be used
to build chains (Xu et al., 2009), and that this leads to Ub
polymers with extremely diverse topologies (reviewed in Koman-
der, 2009), further adding to ubiquitin’s ﬂexibility as a post-
translational modiﬁcation. It is important to note that ubiqui-
tination can be reversed by de-ubiquitinating (DUB) proteases,
so, like other post-translational modiﬁcations, Ub signals can
be precisely controlled. There are also examples of proteins that
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harbor Ub-binding motifs, which, in combination with Ub lig-
ases and DUBs,enable Ub to serve as a reversible protein-binding
surface that allows for regulated generation and subsequent dis-
assembly of protein complexes (reviewed in Hicke et al., 2005;
Dikic et al., 2009). Finally, the ubiquitin domain has been found
to be encoded within the linear sequence of larger proteins.While
several such ubiquitin-like domain (ULD) proteins have been
shown to be involved with protein degradation and proteasome
function, others participate in functions ranging from metabo-
lism to signal transduction, in both prokaryotes and eukaryotes
(reviewedinBurroughsetal.,2007;GrabbeandDikic,2009).Thus,
the small ubiquitin domain and its cognate ubiquitin-binding
domains represent a pair of complimentary structural features
that have seen a great deal of use, reuse, and reassortment during
evolution.
There are of course many examples in which the host itself
uses Ub to limit viral production, particularly via the activation
of NF-κB( r e v i e w e di nSkaug et al., 2009). Likewise, in addition
to Ub, there are other Ub-like (UBL) proteins that are used to
modify and control cellular processes (reviewed in Hochstrasser,
2009). However, because it is the most extensively characterized
of the Ub-like proteins, we have chosen to focus upon Ub itself
and the ways in which viruses exploit this small protein at each
stage of the lifecycle. At the end of the review, we have pro-
vided a ﬁgure that integrates many of the examples discussed
herein.
VIRAL ENTRY AND NUCLEOCAPSID TRANSPORT
There have been no reports of a direct link between the Ub-
proteasome system (UPS) and viral binding to host cells. How-
ever, studies of several viral classes have shown that post-entry
steps such as nucleocapsid transport and/or disassembly are
impaired in the presence of proteasome inhibitors or in cell lines
expressing a temperature sensitive mutant of the Ub-activating
enzyme E1 (ts E1; see Table 1). A more direct role for the UPS
in inﬂuenza virus entry was shown when either depletion of
Epsin 1 or expression of a non-ubiquitinable Epsin 1 mutant
blocked clathrin-mediated viral transport (Chen and Zhuang,
2008). Interestingly, while the nucleocapsid transport of some
parvoviruses (minute virus of mice,MMV and canine parvovirus,
CPV)issensitivetoproteasomeinhibitors(RosandKempf,2004),
the entry of two other family members, bovine parvovirus (BPV)
andadeno-associatedvirus(AAV),wereinsensitivetoproteasome
inhibitors (Yan et al., 2002). In fact, previous studies have shown
that AAV infections are enhanced by proteasome inhibitors in
a process whereby some portion of the intracellular AAV par-
ticles are ubiquitinated and degraded (Yan et al., 2002). All of
the studies using proteasome inhibitors suggest that the UPS is
important for both RNA and DNA virus entry, but the speciﬁc
viral and cellular players remain to be identiﬁed. One exception
is a recent report examining adenovirus entry, which has identi-
ﬁed ubiquitination of the capsid protein VI as a key step in viral
transport to the nucleus. The VI protein contains a PPXY motif
(normally associated with viral egress, see below) that recruits a
member of the neural-precursor-cell-expressed, developmentally
down-regulated (Nedd4) family of E3 Ub ligases, and this inter-
action is necessary for the microtubule-dependent localization of
protein VI. Viruses expressing protein VI with a mutated PPXY
domain can exit endosomes, but are unable to transport to the
nucleus (Wodrich et al., 2010). Finally, the human immunodeﬁ-
ciency virus (HIV)-1 accessory protein Vpr and its HIV-2/simian
immunodeﬁciency virus (SIV) homolog Vpx appear to improve
the ability of their cognate viruses to infect macrophages, and
for some time this was thought to be due to an improvement
in the translocation of the viral pre-integration complex to the
nucleus (references in Casey et al., 2010). However, more recent
work has determined that Vpx overcomes a macrophage-speciﬁc
restriction factor,and that this depends onVpx’s association with
a Cullin (Cul) 4 E3 Ub ligase complex (see below, and Sharova
et al., 2008). While it remains to be seen whether Vpr counter-
acts the same factor in human cells, the observation that Vpx can
enhance dendritic cell and macrophage infection by HIV-1 sug-
gests that this will be the case (see references inAyinde et al.,2010;
Table 1).
Table 1 | Viral entry/nucleocapsid transport.
Viral protein Virus Ubiquitin function modiﬁed Reference
Not known Corona: MHV feline infectious peritonitis virus
(FIPV), severe acute respiratory syndrome (SARS)
Nucleocapsid transport is sensitive to proteasome
inhibitors
Yu and Lai (2005),
Raaben et al. (2010b)
Not known Orthomyxo: inﬂuenza Nucleocapsid transport is sensitive to proteasome
inhibitor and ts E1 mutant
Widjaja et al. (2010)
Viral entry is blocked by knocking down Epsin 1 or
preventing ubiquitination of Epsin 1
Chen and Zhuang (2008)
Not known Parvo: MMV, CPV Nucleocapsid transport is sensitive to proteasome
inhibitor and ts E1 mutant
Ros and Kempf (2004)
Not known Herpes: Herpes simplex virus (HSV) Nucleocapsid transport is sensitive to proteasome
inhibitors
Delboy et al. (2008)
Capsid VI Adeno: Ad5 Ubiquitination of CapsidVI by Nedd4 E3 Ub ligase nec-
essary for microtubule-dependent nucleocapsid trans-
port to nucleus
Wodrich et al. (2010)
Vpx Retro: HIV-2/SIV Interacts with DCAF1/DDB1/Cul 4 E3 Ub ligase to
counteract macrophage-speciﬁc restriction factor
Sharova et al. (2008)
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PROTEASOME INHIBITORS IN VIVO
Becausenumerousinvitrostudieshaveshownthatmultiplepoints
in the viral life cycle can be blocked with proteasome inhibitors,
their potential use as anti-viral agents has been an enthusiastic
topic of discussion. However, recent in vivo studies suggest no
clear consensus for the efﬁcacy of these inhibitors. Several mouse
studies evaluating the proteasome inhibitor bortezomib, which is
clinicallyapprovedformultiplemyeloma,foundthatlymphocytic
choriomeningitis virus (LCMV;Basler et al.,2009),mouse hepati-
tis virus (MHV; Raaben et al., 2010a), and human respiratory
syncytial virus (HRSV; Lupfer et al., 2010) each replicated better
in the presence of bortezomib, so much so that MHV and HRSV
hastened the mortality of infected mice. In contrast, Ma et al.
(2010)showedthattreatmentof MHV-infectedmice(pneumoni-
tis model) with three different proteasome inhibitors (including
bortezomib) resulted in reduced viral replication and a 40% sur-
vival rate. While these studies are not directly comparable due to
the variety of viruses and mouse models employed, they suggest
that much more research is necessary before these inhibitors can
be approved for the treatment of viral infections.
VIRAL TRANSCRIPTION
There are relatively few examples in which viral transcription is
enhanced by manipulation of the UPS. The transactivator pro-
teins encoded by Epstein–Barr virus (EBV), HIV, and human T-
lymphotropic virus (HTLV) each appear to interact with the UPS,
and this results in the enhancement of transactivator function.
The EBV transactivator EBNA1 binds the Ub-speciﬁc-processing
protease 7 (USP7), a cellular DUB, and this augments binding
of EBNA1 to the viral oriP site. This interaction also results in
the deubiquitination of histone 2A at the oriP site (Sarkari et al.,
2009), although the relevance of this histone modiﬁcation to
viral transactivation has not been evaluated. The HIV-1 trans-
activator Tat was shown to be ubiquitinated by Hdm2, which
did not result in degradation of Tat, but instead enhanced viral
transcription from the LTR (Bres et al., 2003). A more recent
paper found that basal (Tat-independent) transcription from the
HIV LTR requires Ski-interacting protein (SKIP) recruitment by
the histone H2B ring ﬁnger protein 20 (RNF20) Ub ligase (Bres
et al., 2009). Similar to Tat, the HTLV-1 transactivator Tax is also
monoubiquitinated (Chiari et al., 2004) and sumoylated (Nasr
et al., 2006). These modiﬁcations appear to enhance Tax’s ability
to activate NF-κB, which in turn is necessary for viral transacti-
vation and is also responsible for the oncogenic properties of the
virus (Nasr et al., 2006; Harhaj et al., 2007). Ubiquitination of
Tax C-terminal lysine residues is necessary for its role in bind-
ing and relocalizing IκB kinase (IKK) from the cytoplasm to
perinuclear regions, which in turn modulates NF-κB activation.
The sumoylation of Tax on overlapping lysine residues mediates
both the development of Tax nuclear bodies (NB) and com-
plete NF-κB activation (Nasr et al., 2006). This same group later
found that a single Tax molecule can be both ubiquitinated and
sumoylated, and that this differential modiﬁcation is responsible
for shuttling Tax and IKK between the cytoplasm, NB, and the
centrosome (Kfoury et al., 2010). The UPS has also been impli-
cated in human cytomegalovirus (HCMV) viral transcription. A
delay in both early and late viral gene expression was observed
in the presence of proteasome inhibitors, which was likely due
to a block in viral RNA transcription. Tran et al. (2010) also
observedthatthe19sproteasomesubunitRpn2relocalizestoviral
replication centers in a viral DNA replication-dependent manner
(Table 2).
VIRAL REPLICATION
The use of proteasome inhibitors and ts E1 have been the main
tools used to link the UPS to the replication of members of sev-
eralvirusfamilies,includingpox,paramyxo,hepadna,andpicorna
(see Table 2). The importance of the UPS to DNA tumor viruses
such as adenovirus during their regulation of the cell cycle and
their inhibition of apoptosis are well known and are discussed in
detail below. Blanchette et al. (2008) have shown that the same
adenoviral E4orf6/E1B55k/Cul5 E3 Ub ligase complex responsi-
ble for degrading p53 and Mre11 is also necessary for viral mRNA
transport from the nucleus. However, the substrate(s) targeted
for ubiquitination in order to achieve this function have yet to
be elucidated. A more recent paper has described a novel use
of the UPS to enhance HIV replication (Zheng et al., 2011). In
a yeast two-hybrid screen using HIV integrase as the “bait,” the
cellular protein Ku70, which is involved in DNA repair, the non-
homologous end-joining pathway, transcription, apoptosis, and
telomere maintenance (reviewed in Downs and Jackson, 2004)
was identiﬁed (Studamire and Goff, 2008). Zheng et al. (2011)
show that Ku70 is incorporated into HIV virions and prevents the
proteasomal degradation of HIV integrase. Furthermore, if Ku70
is knocked down with siRNA, integrase levels are diminished and
viral replication is decreased (Table 2).
VIRAL LYTIC/LATENCY REGULATION
An important aspect of the herpesviral lifecycle is the regulation
of lytic replication and latency. There are now several examples
of UPS involvement in various aspects of this regulation. In par-
ticular,lyticreactivationof Kaposi’ssarcomaherpesvirus(KSHV)
from latency is regulated by at least two UPS-dependent mech-
anisms. The viral replication and transcription activator (RTA)
proteinalsoactsasanE3Ubligasethatubiquitinatesanddegrades
itsownrepressors,includingKSHV-RTAbindingprotein(K-RBP;
Yang et al., 2008) and hairy/enhancer-of-split related with YRPW
motif 1 (Hey1; Gould et al., 2009), which normally limit lytic
replication. Another KSHV protein required for lytic reactiva-
tion is the tegument protein ORF64, which has been identiﬁed
as a viral DUB (Gonzalez et al., 2009). ORF64 cleaves Ub from
both K48- and K63-linked chains and requires a speciﬁc cys-
teine for its DUB activity. While knockdown of ORF64 with
siRNA lowered lytic reactivation and lytic protein expression, a
direct role for DUB activity in this reactivation was not shown.
The murine gammaherpesvirus-68 (MHV68) ORF64 homolog
has also been identiﬁed as a viral DUB. Gredmark-Russ et al.
(2009) found that a virus expressing an ORF64 with an alanine
substitution for the critical active site cysteine was more rapidly
cleared than the wildtype virus in an in vivo mouse model. This
suggested an important role for DUB activity in viral replica-
tion and possibly persistence, although they observed no dif-
ferences in viral genome copy numbers (Gredmark-Russ et al.,
2009). Another MHV68 protein involved in viral persistence is
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Table 2 | Viral transcription, replication, and lytic/latent regulation.
Viral protein Virus Ubiquitin function modiﬁed Reference
EBNA1 Herpes: EBV Interaction with cellular DUB USP7 enhances EBNA1 binding to
oriP and induces ubiquitination of histones
Sarkari et al. (2009)
Tat Retro: HIV-1 Tat ubiquitination by Hdm2 enhances LTR activation Bres et al. (2003)
Tax Retro: HTLV-1 Tax ubiquitination is important for NF-κB activation Nasr et al. (2006), Harhaj et al. (2007)
Unknown Herpes: HCMV Early and late viral transcription is sensitive to proteasome
inhibitors
Tran et al. (2010)
Unknown Pox: vaccinia,
ectromelia and cowpox
Viral replication inhibited by proteasome inhibitors and ts E1
mutant
Satheshkumar et al. (2009),
Teale et al. (2009)
Unknown Paramyxo: HRSV Viral replication inhibited by proteasome inhibitors Lupfer and Pastey (2010)
Unknown Hepadna: hepatitis B
virus (HBV)
Viral replication inhibited by proteasome inhibitors Bandi et al. (2010)
Unknown Picorna: coxsackie Viral replication inhibited by proteasome inhibitors and Ub
knockdown
Wong et al. (2007)
E4orf6/E1B55k Adeno: Ad5 Forms complex with Cul5, which is necessary for viral mRNA
transport from nucleus
Blanchette et al. (2008)
Integrase Retro: HIV-1 Interacts with cellular DNA repair protein Ku70, which prevents its
own proteasomal degradation, thus enhancing viral replication
Zheng et al. (2011)
RTA Herpes: KSHV E3 Ub ligase activity degrades repressors, K-RBP , and Hey1
leading to lytic viral replication
Yang et al. (2008), Gould et al. (2009)
ORF64 Identiﬁed as viral DUB. May be involved in lytic reactivation Gonzalez et al. (2009)
ORF64 Herpes: MHV68 Identiﬁed as viral DUB. Virus with mutated DUB cleared faster
in vivo
Gredmark-Russ et al. (2009)
ORF73 Associates with ElonginC/Cul5/SOCS-like complex to ubiquitinate
and degrade RelA/NF-κB, which may facilitate viral persistence
Rodrigues et al. (2009)
LMP2A Herpes: EBV Ubiquitinated and degraded by c-Cbl E3 Ub ligase, thereby
preventing lytic replication and promoting latency
Ikeda and Longnecker (2009)
LMP1 Regulates lytic replication by inducing the cellular DUB A20, which
inactivates IRF7 via deubiquitination
Ning and Pagano (2010)
ORF73. Recent evidence suggests that ORF73’s abilities to both
assemblewithanElonginC/Cul5/suppressorof cytokinesignaling
(SOCS)-like complex and effect the ubiquitination and degra-
dation of RelA/NF-κB may be responsible for maintaining viral
infection. In an in vivo mouse model, an MHV68 virus with a
mutation of the ORF73 SOCS-box motif was unable to induce
B-cell proliferation or set up a persistent infection,suggesting that
NF-κB plays a role in these processes (Rodrigues et al., 2009).
However, while the degradation of NF-κB also has the potential
to impact interferon (IFN) induction (see below), this was not
investigated.
An interesting twist on the role of the UPS in the regulation
of viral latency is provided by the herpesvirus EBV. The viral
latent membrane protein 2A (LMP2A) has been implicated in
the regulation of both EBV latency and oncogenesis through its
action as a B-cell receptor (BCR) mimic that constitutively acti-
vates the Lyn and Syk protein tyrosine kinases (reviewed in Portis
etal.,2004).Todetermineif LMP2AisregulatedsimilarlytoBCR,
Ikeda and Longnecker (2009) investigated the role that c-Cbl, an
E3 Ub ligase that negatively regulates B-cell signaling, might play
in LMP2A regulation. They discovered that LMP2A is ubiquiti-
nated and degraded in a c-Cbl-dependent manner and that the
Syk kinase is also degraded by c-Cbl in the presence of LMP2A.
In addition, when c-Cbl was knocked down with shRNA, LMP2A
induced lytic gene expression. Together with previous data show-
ing that LMP2A contains two PPXY motifs and recruits Nedd4
Ub ligase to degrade Lyn kinase (Ikeda et al., 2001), these ﬁnd-
ings suggest that the cellular UPS is an important factor in the
maintenance of EBV latency. In a similar story, the EBV LMP1
protein also appears to modulate latency through its interaction
with the UPS. LMP1 stimulates the TNF receptor associated fac-
tor6(TRAF6)E3ligase-dependentubiquitinationofIFNresponse
factor(IRF)7,andthismodiﬁcationisrequiredforthesubsequent
phosphorylation of IRF7 by RIP1 kinase (Ning et al.,2008). If left
unchecked, this would lead to activation of lytic replication and
IFNinduction.However,LMP1wasalsorecentlyshowntoinduce
the cellular DUB A20, which inactivates IRF7 via deubiquitina-
tion (Ning and Pagano, 2010). Whether these intricate regulatory
mechanisms are more advantageous for the cell or virus remains
to be determined.
CELL CYCLE REGULATION, INHIBITION OF APOPTOSIS AND
CELLULAR PROLIFERATION
The “high risk” oncogenic human papillomaviruses (HPV) pro-
vided the very earliest examples of viruses that utilize the host
UPS to destroy host proteins. The HPV-encoded E6 and E7 pro-
teins, which are best known for their ability to degrade p53 and
pRb, respectively, can efﬁciently induce cellular transformation
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(reviewed in Mammas et al., 2008). The goal of such activities is
presumablytoextendthelifespanof infectedcells,sothatthevirus
can either pursue a latent lifestyle or increase viral proliferation
priortocelldeath.Sincethoseinitialobservations,numerousother
viruses have been shown to follow a similar program (Table 3).
HUMAN PAPILLOMAVIRUSES E6
HumanpapillomavirusesE6canfunctionasanadaptortoredirect
the cellular E6-associated protein (E6AP) HECT ligase to target a
number of cellular proteins for proteasome-dependent degrada-
tion (see Table 3). Chief among these is p53, which appears to be
upregulated by the activities of HPV E7 (Demers et al., 1994, and
see below). E6 can also target a number of PDZ [post synaptic
density protein (PSD95), Drosophila disk large tumor suppressor
(DlgA), and zonula occludens-1 protein (zo-1)]-domain proteins
for degradation independently of E6AP, including human disks
large(hDlg),membrane-associatedguanylatekinasewithinverted
orientation 1, 2, and 3 (MAGI), and hScrib (Mammas et al.,
2008). More E6 targets continue to be discovered. For exam-
ple, E6 has recently been found to augment Wnt signaling in an
E6AP-dependent manner,suggesting thatWnts may play a role in
HPV carcinogenesis (Lichtig et al., 2010). In a search for the cel-
lular proteins targeted by E6 to stimulate Wnt signals, Rampias
et al. (2010) found that the cellular E3 ligase seven in absen-
tia homolog (Siah-1), which is known to promote beta-catenin
degradation via the UPS, is inhibited by the combination of HPV
E6 and E7. This provides evidence for what may be an interest-
ing example of a virus redirecting a cellular E3 ligase (E6AP) to
target another cellular E3 ligase (Siah-1).Yet another player in the
p53pathway,thetumorsuppressorTat-interactingprotein60kDa
(TIP60),istargetedforproteasome-dependentdegradationbyE6,
although this does not require E6AP (Jha et al., 2010). TIP60
was found to bind to the HPV major early promoter, recruiting
a cellular repressor of E6 expression in the process. Therefore,
Table 3 | Cell cycle regulation/inhibition of apoptosis/cell proliferation.
Viral protein Virus Ubiquitin function modiﬁed Reference
E6 Papilloma: HPV Interacts with HECT ligase E6AP to induce proteasomal
degradation of p53, Bak (Bcl-2 homologous antagonist/killer),
E6TP1 (E6 targeting protein 1), cMyc, MMP7 (matrix
metalloprotease 7), Mcm7 (minichromosome maintenance protein
7), NFX1 (nuclear transcription factor, X-box binding 1), and Siah-1
(seven in absentia homolog 1)
Reviewed in Banks et al. (2003),
Shackelford and Pagano (2004),
Mammas et al. (2008), Howie et al.
(2009), Lagunas-Martinez et al.
(2010), Rampias et al. (2010)
E7 Interacts with Cul2/ElonginBC/Rbx1 to induce degradation of pRB,
interacts with the cellular DUB USP11 to prevent its own
degradation, and induces Ub and degradation ofTIEG1
Boyer et al. (1996), Huh et al. (2007),
Lin et al. (2008), Chang et al. (2010)
E2 Interacts with E3 Ub ligase APC and induces G2/M arrest Bellanger et al. (2005)
E5 Stabilizes EGF-R by preventing degradation via E3 Ub ligase c-Cbl
and induces Bax degradation, thereby inhibiting apoptosis
Zhang et al. (2005), Oh et al. (2010)
E4orf6 and E1B55k Adeno: Ad5 Complexes with E3 Ub ligase Cul5/ElonginB/C/Rbx1 to induce
degradation of p53, DNA ligase IV, and MRN DNA repair complex
proteins
Reviewed in Blanchette and Branton
(2009), Isaacson and Ploegh (2009),
Randow and Lehner (2009)
E4orf6 Adeno: Ad12 Interacts with E3 Ub ligase Cul2/Rbx1/ElonginC to induce Ub and
degradation of ATR activator proteinTOPBP1
Blackford et al. (2010)
E4orf4 Adeno Activates E3 Ub ligase APC, leading to the enhanced degradation
of securin/Pds1, resulting in G2/M arrest
Mui et al. (2010)
BPLF1 Herpes: EBV DUB activity removes Nedd8 from Cul1 and Cul4a, thereby
stabilizing CDT1, which leads to S-phase
Gastaldello et al. (2010)
EBNA3c Induces Ub and degradation of pRb and p27 via E3 Ub ligase SCF
(Skp2) complex, and DUB activity prevents degradation of Cyclin
D1 promoting G1/S transition
Knight et al. (2005a), Saha et al.
(2009, 2011)
X Hepadna: HBV Interacts with DDB1 component of E3 Ub ligase Cul4a, resulting
in stabilization of PTTG1, a possible factor in hepatocellular
carcinoma
Martin-Lluesma et al. (2008), Molina-
Jimenez et al. (2010)
PACR Pox Inhibits APC E3 ligase complex, which may induce S-phase and
increased viral DNA replication
Mo et al. (2009)
Vpr Retro: HIV-1 Interacts with DCAF1/DDB1/Cul4 E3 Ub ligase, resulting in G2
arrest
References in Casey et al. (2010)
LargeT Polyoma: SV40 Interacts with Fbw7 , inhibiting the E3 Ub ligase
Skp1/Cul/Rbx1/Fbw7 , which results in increased Cyclin E levels
Welcker and Clurman (2005)
E1A Adeno Interacts with Fbw7 , inhibiting the E3 Ub ligase
Skp1/Cul/Rbx1/Fbw7 , which may increase proliferation
Isobe et al. (2009)
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degradation of TIP60 serves to derepress both E6 expression as
well as cellular genes whose products limit p53-dependent apop-
tosis. As mentioned above, the cellular E6AP HECT ligase is
variably required for E6 phenotypes. A recent study examined
the requirement for E6AP in clinical HPV outcomes (Shai et al.,
2010). Using a transgenic mouse model of HPV oncogenic phe-
notypes, they found that while E6AP is dispensable for epithelial
hyperplasia and the limitation of DNA damage responses, E6AP
is absolutely required for cervical carcinomas. Therefore, while
this cellular E3 ligase may not be necessary for all E6 functions,
it still has an impact upon the most serious consequence of HPV
infection.
HUMAN PAPILLOMAVIRUSES E7
E7istheotherprimarycontributortoHPV-mediatedtransforma-
tion. Members of the cellular pRb/pocket protein family normally
function to control G1/S-phase progression by inhibiting the E2F
family of transcriptional activators, which in turn control the
transcription of S-phase promoters (Moody and Laimins, 2010).
The most well-characterized E7 function is to target pRb family
members for UPS-dependent degradation, thereby derepressing
E2F-dependent promoters (Boyer et al., 1996). At the same time,
E7 is a relatively unstable protein (Selvey et al., 1994) that has
been found to be ubiquitinated on its N-terminal residue and
then destroyed by the proteasome (Reinstein et al., 2000; Wang
et al.,2001).While E7 has been detected in complexes with several
E3 ligases (Kamio et al., 2004; Oh et al., 2004), of those, the only
E3 complex also shown to contain pRb is Cul2/ElonginBC/Rbx1
(Huh et al., 2007), suggesting that this is the Ub ligase respon-
sible for pRb degradation. Lastly, in what is perhaps an attempt
to counter the host’s efforts to destroy it, E7 also interacts with
the cellular DUB USP11, which leads to the stabilization of E7
(Lin et al., 2008). While E7 interacts with many cellular proteins
to dysregulate the host cell cycle, aside from pRb, few others have
been shown to be targeted for degradation. Chang et al. (2010)
have recently added to this list the transforming growth factor-
beta inducible early gene-1 (TIEG1), a transcription factor that
can induce apoptosis in carcinoma cell lines. E7 binds directly to
TIEG1, and TIEG1 is subsequently ubiquitinated and degraded
via the proteasome, further contributing to E7-induced cellular
transformation.
HUMAN PAPILLOMAVIRUSES E2
The HPV protein E2 is a DNA-binding protein that can both acti-
vate and repress the transcription of viral promoters (reviewed in
Lagunas-Martinez et al., 2010). Interestingly, HPV E2 normally
represses the transcription of the genes encoding E6/E7. However,
in cells infected with high risk HPV’s,the viral genome frequently
integrates into that of the host, and HPV E2 is inactivated in the
process. HPV E2 has also been shown to interfere with cellular
pathwaysinaUb-dependentmanner.Forexample,HPVE2inter-
acts with the Cdc20 and Cdh1 substrate-speciﬁcity subunits of
the anaphase promoting complex (APC) E3 ligase. This inhibits
normal APC-dependent Cyclin B degradation, thereby leading to
G2/M arrest (Bellanger et al., 2005). It has recently been shown
that HPV E2 binds to Skp2, an F-box protein that serves as a
speciﬁcity determinant for the SCF complex. In this way, HPV
E2 is targeted for ubiquitination and subsequent proteasomal
degradation. However, Skp2 is itself a known APC target, and
APC-dependent Skp2 degradation is required to maintain cells in
G1.BecauseHPVE2interfereswithAPC(seeabove),thissuggests
a criss-crossing autoregulatory loop in which HPV E2 interferes
withAPC,thus stabilizing Skp2 and promoting G1/S progression.
Once Skp2 reaches sufﬁcient levels, Skp2/SCF ubiquitinates and
degrades HPV E2,which de-represses HPV E6 and E7 expression.
This combination tends to push the host cell toward S-phase,and
perhaps into transformation (Bellanger et al.,2010).
HUMAN PAPILLOMAVIRUSES E5
Although it has been shown to induce epithelial cell hyperpro-
liferation when overexpressed in transgenic mice (Maufort et al.,
2010), HPV E5 has primarily been characterized as a mere con-
tributor to E6/E7-driven transformation (reviewed in Moody and
Laimins, 2010). Due to its ER localization and proposed inhibi-
tion of endosome acidiﬁcation,it is thought that HPV E5 impacts
the trafﬁcking of proteins such as EGF-R, which enhances pro-
liferative cell signaling (Leechanachai et al., 1992; Straight et al.,
1995). A role for Ub in this process was provided by the obser-
vation that E5 binding to EGF-R prevents the receptor from
binding to the cellular E3 c-Cbl (Zhang et al., 2005), which is
involved in normal EGF-R receptor downregulation. This stabi-
lizes EGF-R and leads to constitutive signaling. In what appears
to be yet another Ub-dependent E5 phenotype, Oh et al. (2010)
have recently shown that the HPV16 E5 contribution to cervi-
cal cancer may lie in its ability to limit Bax-dependent apoptosis
of infected cells. Expression of E5 induced the degradation of
Bax in a UPS-dependent manner. E5 may therefore function
as an adaptor that targets cellular proteins for ubiquitination,
and this may be responsible for other established E5 activities
as well.
ADENOVIRUS
Like the high risk HPVs, adenoviral infection can also result
in host cell transformation. The primary culprits here are the
viral proteins E4orf6 and E1B55k, which combine to effect the
UPS-dependent degradation of host proteins related to cell cycle
regulation and DNA damage repair (see Table 3). E4orf6 func-
tions as an adaptor that links E1B55k to various Cul containing
E3complexes.E1B55kthenactsasasubstraterecognitionsubunit
that redirects the new E3 complex to various cellular targets. The
prevention of apoptosis leads to the accumulation of DNA dam-
agewithininfectedcells.ToavoidcellularDNAdamageresponses,
adenovirus blocks the ATM (ataxia telangiectasia mutated) and
ATR (ATM and Rad3-related) pathways (Carson et al., 2003).
Most Adenovirus serotypes, including Ad5 and Ad12, prevent
the activation of the ATM pathway by inducing the degradation
of the MRN (Mre11, Rad50, and Nbs1) DNA damage complex
via the mechanism just described. However, it has recently been
shown thatAd5 andAd12 prevent the activation of theATR path-
way in different ways. Prior to the E4orf6/E1B55K-dependent
degradation of the MRN complex, Ad5 utilizes E4orf3 to mis-
localize and immobilize the MRN complex, which prevents ATR
activation (Carson et al., 2009). In contrast, Ad12 E4orf3 does
not appear to have this function. Instead, Ad12 E4orf6 (without
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E1B55k) interacts with a Cul2/Rbx1/ElonginC ligase to promote
the UPS-dependent degradation of the ATR activator protein
topoisomerase-ILβ-binding protein-1 (TOPBP1), thereby block-
ing ATR activation (Blackford et al., 2010). This observation of
differential Cul usage by adenoviruses has been extended even
further. In a recent survey of all adenoviral subgroups, it was
found that while all E4orf6/E1B55k pairs associate with Cul fam-
ily members,the particular Cul varies.Among the serotypes,Cul5
is most frequently bound, but some serotypes recruit Cul2, and
Ad16 E4orf6/E1B55k recruited both Cul2 and Cul5 equally well.
WhileallserotypesdegradedDNAligaseIV,complexesfromsome
serotypes failed to degrade Mre11, p53, or integrin α3, suggest-
ing that the choice of Cullin may in part dictate which targets are
destroyed (Cheng et al., 2010).
Finally, the adenoviral protein E4orf4 is known to induce cell
deathviaanumberof cell-typespeciﬁcmechanisms(Robertetal.,
2002). One commonality amongst these mechanisms is the modi-
ﬁcationof theAPCE3ligaseactivity,althoughithasbeenreported
that E4orf4 can both reduce (Kornitzer et al., 2001) and induce
(Mui et al., 2010) APC activity to achieve this end. In the latter
case, E4orf4 expression led to degradation of the APC substrate
Pds1/securin,aproteinthatisrequiredforthecompletionofmito-
sis. Thus,it appears that yet another adenoviral protein can,albeit
indirectly, redirect the host Ub system to target host proteins that
disrupt the cell cycle.
HERPESVIRUS
The herpesviral large tegument proteins harbor a cysteine pro-
tease catalytic site that shows little homology to known DUBs,but
nevertheless has been shown to display DUB activity (Kattenhorn
etal.,2005).Asdiscussedabove,theKSHVandMHV68largetegu-
ment homologs (ORF64) have been implicated in the regulation
of the lytic/latent balance. Mutation of the active site residues in
the Marek’s disease virus homolog lowered viral replication and
reduced the number of T-cell lymphomas among infected chick-
ens (Jarosinski et al., 2007). A similar mutation introduced into
Pseudorabies virus likewise impaired viral replication and low-
ered virulence (Bottcher et al., 2008). A bioinformatics approach
was used to search the EBV genome for proteins encoding DUB
activity,revealingBSLF1,BXLF1,andtheEBVlargetegumentpro-
tein BPLF1 (Sompallae et al., 2008). In a follow-up paper, the
same group focused on BPLF1 and found that it functions to
dysregulate the host cell cycle in an effort to promote viral DNA
replication(Gastaldelloetal.,2010).Thiswasshowntodependon
BPLF1’s ability to proteolytically remove the ubiquitin-like mod-
iﬁer protein NEDD8 from Cul1 and Cul4a. This in turn leads to
the stabilization of the Cul substrate CDT1, which then pushes
the host cell toward S-phase. The authors found a similar activity
encodedbytheHSVandMCMVlargetegumentproteins,suggest-
ing that perhaps all herpesviruses utilize their tegument proteins
in this manner.
In addition to BPFL1, EBV encodes numerous other pro-
teins that contribute to cellular transformation. Among these is
EBNA3c, which is itself ubiquitinated (Knight et al., 2005b), and
targets pRb and p27 for degradation by recruitment of the SCF
(Skp2) E3 Ub ligase complex (Knight et al., 2005a; Saha et al.,
2009). EBNA3c has also been shown to have a DUB activity that
can remove Ub from itself. Interestingly, EBNA3c was found in
complexes with both p53 and Mdm2, the cellular E3 responsi-
ble for p53 ubiquitination. More recently EBNA3c was shown
to prevent the degradation of Cyclin D1, which overrides the
activity of the tumor suppressor pRb and thereby promotes
G1/S-phase transition (Saha et al., 2011). Thus, EBNA3c appears
to both positively and negatively modulate the ubiquitin sta-
tus of a number of proteins whose dysregulation can promote
tumorigenesis.
HEPADNAVIRUSES
HepatitisBvirus(HBV)isoneof theprimarycausesof hepatocel-
lularcarcinoma(HCC),andtheviralproteinHBxhasbeenshown
to promote cell cycle progression via a number of mechanisms
(reviewed in Kew, 2011). While a role for ubiquitin was not ini-
tially appreciated,it was found that HBx binds to damage-speciﬁc
DNA-binding protein 1 (DDB1; Lee et al.,1995),and that numer-
ous HBx phenotypes depend upon this interaction (see references
in Martin-Lluesma et al., 2008). The later ﬁnding that DDB1 is a
part of Cul4a E3 ligase complex (Shiyanov et al., 1999) suggested
that HBx functions to interfere with such complexes, resulting in
many of the HBx phenotypes. One recent paper has shown that
HBx stabilizes the proto-oncogene pituitary tumor-transforming
gene 1 (PTTG1) protein, which is known to be overexpressed in
HCC(Molina-Jimenezetal.,2010)andwhichhaspreviouslybeen
shown to bind to and inhibit p53 (Bernal et al., 2002). However,
whether PTTG1 ubiquitination is directly or indirectly inhibited
by HBx remains to be determined.
POXVIRUS
Unlike the other viruses described in this section, the members
of the poxvirus family are not well known for their ability to
interfere with the host cell cycle. However, there have been sev-
eral reports noted for vaccinia (Koziorowska et al., 1971; Puckett
and Moss, 1983; Yoo et al., 2008). Poxviruses are presumed to
manipulate the host ubiquitin system via (a) their ankyrin-like
proteins,which have been found to interact with Cul1 ligase com-
plexes, (b) their BTB-Kelch proteins, which interact with Cul3
ligase complexes (reviewed in Shchelkunov, 2010), and (c) their
conserved p28 proteins that are E3 ligases (Huang et al., 2004).
Amongst these, only the Myxoma M-T5 ankyrin repeat protein
has been shown to affect the cell cycle,and it does so by overcom-
ing the G0/G1 arrest that normally takes place in infected cells.
However, a direct role for ubiquitin in this process has not been
shown (Johnston et al., 2005). Interestingly, several poxviruses
were recently found to encode a RING domain protein referred
to as poxvirus APC/cyclosome activator (PACR), which inhibits
thefunctionof theAPCE3ligasecomplex(Moetal.,2009).PACR
is homologous to the RING domain protein APC11, which is the
APC subunit responsible for binding to Ub-charged E2 ligases.
That same group’s subsequent ﬁnding that PACR competes with
APC11 for binding to the APC complex suggests that PACR is a
dominantnegativeinhibitorof theAPCcomplex(Moetal.,2010).
Because APC normally functions to maintain cells in a quiescent
state,the authors suggest that PACR-dependent inhibition of APC
may promote viral DNA replication by pushing host cells toward
S-phase.
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HUMAN IMMUNODEFICIENCY VIRUS-1
The small accessory proteins encoded by HIV-1 (and variably by
HIV-2 and SIV) include Vif, Vpu, and Vpx/Vpr. Each of these
proteins has been shown to function as adaptors for various
Cul-based E3 ligase complexes, which, at least in the case of Vif
and Vpu, have clear beneﬁts for the virus with respect to repli-
cation and egress (see below). Among the numerous activities
attributed to Vpr, only a subset has been shown to depend upon
Vpr’s ability to associate with the DDB1-Cul4 associated factor
1 (DCAF1), which functions as the speciﬁcity determinant for a
Cul4 E3 ligase complex (see references in Casey et al., 2010). In
the mid-1990s, several laboratories observed that Vpr induces a
G2cellcyclearrestindividingcells(Jowettetal.,1995;Rogeletal.,
1995). While the beneﬁt to the virus remains unclear, many other
groups subsequently found that this activity is dependent upon
Vpr’s engagement of the DCAF1/DDB1/Cul4 Ub ligase. However,
due to the Vpr-induced change in the levels of a large number
of host proteins, which includes transcription factors, cytokines,
and chemokines (see references in Casey et al., 2010), some have
argued that the G2 arrest is a mere byproduct of those changes.
In support of this notion, one group has shown that Vif can also
a rr e s tc e l l si nG 2( DeHart et al.,2008),and others have found that
DCAF1 is itself required for normal S-phase progression (McCall
et al., 2008). These ﬁndings suggest that the titration of host Ub
ligases may result in G2 arrest,and perhaps otherVpr phenotypes
as well.
VIRAL BUDDING
Oneof themoreintriguingaspectsof thevirallifecycleistheman-
ner in which enveloped viruses acquire their membranes. After
the assembly of viral proteins at host membranes, the subsequent
formation of a mature viral particle requires the deformation of
the membrane,gathering it around the viral particle,culminating
in an energetically unfavorable “pinching-off” event that sepa-
rates the viral envelope from the host membrane. Although there
appeartobeexamplesof virusesthatrelysolelyontheirowninte-
gralmembraneproteinstoaccomplishthisfeat(reviewedinChen
and Lamb,2008),many other viruses instead require both Ub and
the host vacuolar protein sorting (VPS) machinery (reviewed in
Martin-Serrano,2007). The general story that has emerged is that
viral budding proceeds in a manner analogous to that in which
ubiquitinated membrane proteins destined for lysosomal degra-
dation are recognized by the host VPS machinery, packaged into
multivesicular bodies (MVB; reviewed in Davies et al., 2009), and
then delivered to lysosomes. For those viruses whose budding
is VPS-dependent, their viral Gag or matrix proteins are found
to harbor so-called late budding domains (L-domains), which
are short motifs that function as binding sites for various VPS
components. L-domains are so named because mutations within
these motifs lead to the formation of viral particles with mem-
branes that have failed to complete the budding process. There
appear to be three primary classes of L-domains; PT/SAP, which
interacts with tumor susceptibility gene 101 (Tsg101), a compo-
nent of theVPS complex endosomal sorting complex required for
transport-I (ESCRT-I), PPXY, which interacts with members of
the Nedd4 family of Ub ligases, and YPDL, which interacts with
apoptosis-linked-gene-2 product, ALG-2–interacting protein X,
(ALIX; reviewed in Chen and Lamb, 2008; Calistri et al., 2009).
Remarkably,L-domainsappeartobeinterchangeable,andinsome
cases, a single Gag/Matrix protein will encode more than one
L-domain. Once an L-domain is recognized by its cognate VPS
component(s),itisthoughtthattheESCRTmachinery(including
ESCRT-I,-II,and-III)isrecruitedtosupplytheforcenecessaryfor
virusbudding.AroleforUbinthisprocessﬁrstcamefromstudies
showing that retroviral Gag proteins were ubiquitinated (Putter-
man et al.,1990; Ott et al.,1998). Likewise,proteasome inhibitors
havebeenshowntopreventbudding(Patnaiketal.,2000;Schubert
et al.,2000; Strack et al.,2000). The ﬁnding that PPXY L-domains
bindNedd4E3ligasesfurthersupportedaroleforubiquitination.
In an effort to determine if L-domains are themselves ubiquiti-
nated, several groups have mutated all lysines within the vicinity
of L-domains,and while this inhibits budding in some cases (Spi-
del et al., 2004; Gottwein et al., 2006), in others, it has little effect
(Zhadinaetal.,2007).However,becauseSer,Thr,andCysresidues
are now recognized as alternate“ubiquitin acceptors,”many of the
earlierstudiesthatsolelyfocusedonlysinewillperhapsneedtobe
revisited.
RETROVIRUSES
In an attempt to clarify the requirement for Ub in retroviral bud-
ding, Zhadina and Bieniasz (2010) have recently engineered a
foamyvirusGagproteinthatgeneratesVLPswhenprovidedwitha
variety of L-domains.When Nedd4-dependent PPXY motifs were
inserted,they found that budding occurred,and that Gag was not
ubiquitinated in the process. Because catalytically active Nedd4
ligases were required, their data suggests that if Gag is not ubiq-
uitinated, a cellular protein(s) is instead targeted. However, when
they generated Gag variants without an L-domain, but that were
directly fused to Ub, budding was efﬁcient, and depended upon
an intact Vps system. This somewhat perplexing result hints at
the plasticity of the system, and indicates that as long as ubiqui-
tination occurs in the vicinity of the L-domain, budding can take
place. Similar results have also been obtained for HIV-1 by Weiss
et al. (2010) who ﬁnd that a number of Nedd4 ligases, including
yeast Rsp5, will promote VLP formation when targeted to Gag,
butthatbuddingdoesnotcorrelatewiththeabilityof theseligases
to ubiquitinate Gag. The identity of at least one cellular ubiquiti-
nation target is perhaps suggested by Sette et al. (2010) who have
recentlyprovidedevidencethatALIXbindstoHIV-1Gag,recruits
Nedd4.1, and is then itself ubiquitinated by Nedd4.1 to promote
egress.
FILOVIRUSES
LiketheretroviralGagproteins,theVP40matrixproteinsencoded
by both Ebola (Harty et al., 2000) and Marburg (Urata et al.,
2007) viruses can form VLPs in the absence of other viral pro-
teins. Ebola VP40 harbors both PPXY and PT/SAP L-domains,
and appears to engage both Nedd4 and Tsg101,respectively (Tim-
minsetal.,2003).Ontheotherhand,Marburgvirusencodesonly
a PPXY motif. Interestingly,it has been shown that while deletion
of the PPXY motif severely limits Marburg VLP formation, co-
expression of the viral nucleoprotein (NP), or glycoprotein (GP)
with theVP40 PPXY mutant rescues budding (Urata et al.,2007).
InthatsamepaperitwasfoundthatTsg101isrecruitedtoVP40in
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a PPXY-dependent manner, providing a unique example of non-
PT/SAP-dependentTsg101interaction.Thissamegrouphasmore
recently shown that the Marburg VP40 PPXY motif also interacts
with Nedd4 (Urata and Yasuda, 2010). Coupled with their earlier
data, this result indicates that the ﬁloviruses require both Nedd4
and Tsg101 for VLP formation, and that at least in the case of
Marburg, NP and/or GP may also play a role in recruiting those
proteins.
PARAMYXOVIRUSES
TheparamyxovirusesareanothergroupofenvelopedRNAviruses,
which appear less consistent in their use of L-domains and the
MVB apparatus. For example, parainﬂuenza virus 5 (PIV5) bud-
ding requires matrix (M), nucleocapsid (NP), and spike glyco-
proteins (Schmitt et al., 2002), none of which appear to encode
obvious L-domain sequences. However, PIV5 budding has been
showntodependonthehostVPSmachinery,aswellastobesensi-
tive to proteasome inhibitors, suggesting commonalities between
the retro- and ﬁloviral budding pathways (Schmitt et al., 2005).
Interestingly, the PIV5 M protein was found to harbor a unique
FPIV L-domain that was discovered via complementation of an
HIV-1 PTAP Gag mutant (Schmitt et al., 2005). Mutation of that
motif in a recombinant PIV5 virus led to drops in viral titers by
ﬁve orders of magnitude compared to the wildtype, demonstrat-
ing the importance of this sequence to viral production. However,
it remains to be seen if the PIV5 FPIV motif functions as a bind-
ing site for either ESCRT components or Nedd4 ligases. While
present in some paramyxoviruses, the FPIV motif is not observed
in the M proteins from measles, Sendai, and Nipah virus, sug-
gesting variability in paramyxoviral budding pathways. Support
for this notion comes from studies of Nipah virus,which encodes
an M protein that is necessary and sufﬁcient for VLP production
(Ciancanelli and Basler, 2006). Wang et al. (2010) have recently
shownthatpriortobuddingfromthehostplasmamembrane,the
Nipah M protein must ﬁrst pass through the nucleus. Treatment
of infected cells with proteasome inhibitors trapped M protein
withinthenucleus,andlikePIV5,loweredviraltiterssubstantially,
suggesting that ubiquitination is involved in M protein trafﬁck-
ing. The authors went on to provide evidence that M protein is
monoubiquitinated on four separate residues, including a lysine
withinaputativebipartitenuclearlocalizationsignal,andthatthis
samelysineislikelytobeubiquitinatedinorderforMproteintobe
exported from the nucleus. They ﬁnished by showing that Nipah
virus release was sensitive to levels of the proteasome inhibitor
bortezomib that are readily achievable in human patients. While
the precise mechanisms are not known, it is clear that Ub plays
a role in the Nipah virus lifecycle. However, because proteasome
inhibitorsappeartoblockupstreamevents(e.g.,Mproteinrelease
from the nucleus), a speciﬁc role for Ub in Nipah budding is less
certain.
RHABDOVIRUSES
SimilartootherGag/Matrixproteinsdiscussedabove,thevesicular
stomatitis virus (VSV) M protein can promote VLP formation in
theabsenceof otherviralproteins(Hartyetal.,1999),andthishas
been shown to depend upon a PPXY motif within the M protein
(Craven et al., 1999). As one might expect for PPXY L-domain
proteins, VSV M protein was found to bind Nedd4 E3 ligases,
and proteasome inhibitors limit viral release, suggesting that Ub
is involved (Harty et al.,2001). However,unlike other viruses that
utilize PPXY L-domains,VSV budding does not appear to depend
upon either Tsg101 or downstream players in the ESCRT pathway
(Irie et al.,2004),indicating that the combination of an L-domain
and a Ub-dependent budding mechanism is not a guarantee of
dependence upon the hostVPS pathway.
ARENAVIRUSES
The Lassa virus matrix protein (Z) alone results in the production
ofVLPs,andharborsbothPTAPandPPXYL-domains(Perezetal.,
2003;Eichleretal.,2004).SimilartootherenvelopedRNAviruses,
it has been demonstrated that budding of Lassa virus Z-protein
VLPs is dependent upon Tsg101 and other ESCRT components
(Urata et al.,2006). However,while the New World Tacaribe virus
Z protein also promotes VLP budding, it harbors no obvious L-
domainsequencesandisnotdependentuponTsg101(Urataetal.,
2009). Nevertheless, Tacaribe Z-protein budding was still shown
to require downstream Vps components, and so it is likely that
arenavirus budding will, in general, depend upon the host MVB
pathway.
DNA VIRUSES
While not all enveloped viruses bud through the plasma mem-
brane, they are still faced with the same mechanistic problems.
HBV budding can be subcategorized into the formation of either
non-infectioussubviralparticles(SVP,composedof onlythethree
viral envelope proteins), or fully infectious particles (recently
reviewed in Patient et al., 2009), each of which appears to bud
through cytoplasmic membranes. Interestingly, release of infec-
tious HBV from cells has been shown to depend on the host VPS
pathway (Kian Chua et al., 2006; Lambert et al., 2007; Watanabe
et al., 2007). Moreover, the HBV core protein harbors a PPXY
motif that has been shown to interact with Nedd4 (Rost et al.,
2006), implicating a role for ubiquitination. Mutation of the two
Lys residues within the core protein had no effect on budding
(Garciaetal.,2009),but,asdescribedabove,alternateUbacceptor
residues may instead be targeted. Members of the herpesviridae
appear to sequentially bud ﬁrst through the inner nuclear mem-
brane and then again through the TGN membrane (reviewed in
Mettenleiter et al.,2009). The release of both Herpes simplex virus
1 (HSV-1; Calistri et al., 2007; Crump et al., 2007; Pawliczek and
Crump,2009)andHCMV(Tandonetal.,2009)particleshasbeen
showntorequirecomponentsoftheMVBpathway,suggestingthat
this may be a common theme among the herpesviruses. However,
thedetailsregardingtheiruseof Ubinthesebuddingeventsawaits
further experimentation.
VIRAL RELEASE
The recent identiﬁcation of Tetherin (BST-2/CD317/HM1.24) as
an IFN-induced anti-viral factor that restricts the egress of HIV-
1 and other enveloped viruses by tethering mature virions to the
hostcellsurface(Neiletal.,2008;Jouvenetetal.,2009)hasrevealed
additional viral countermeasures that require the assistance of the
UPS. The ability of the HIV-1 accessory protein Vpu to enhance
viral release has been known for quite some time, however the
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mechanism for this function was not clear. Viral egress appeared
to be separable from Vpu’s prominent role in inducing the ER-
associated proteasomal degradation of the HIV-1 receptor, CD4
(Schubert and Strebel,1994;Schubert et al.,1996),although some
viral release enhancement has been attributed to CD4 depletion
(Bour et al., 1999). However, recent evidence suggests that, simi-
lar to the situation with CD4,Vpu acts as a substrate recognition
factor for an SCF Ub ligase complex to target Tetherin for down-
regulation (Van Damme et al.,2008; Douglas et al.,2009; Gofﬁnet
et al.,2009; Iwabu et al.,2009; Mangeat et al.,2009; Mitchell et al.,
2009). Several studies by our group and others have concluded
that in contrast to CD4, Vpu promotes the degradation of Teth-
erin within the lysosome (Douglas et al., 2009; Iwabu et al., 2009;
Mitchelletal.,2009),althoughundercertainconditionsproteaso-
maldegradationhasbeenobserved(Gofﬁnetetal.,2009;Mangeat
et al., 2009; reviewed in Douglas et al., 2010). A recent paper sug-
gests that Vpu-mediated ubiquitination of Tetherin can occur on
alllysineandnon-lysineUbtargetsinthecytoplasmictail(Tokarev
et al.,2010). Before this tethering function was known,our group
had identiﬁed BST-2 in a proteomics screen for targets of the viral
Ub-ligaseK5ofthegammaherpesvirusKSHV(Barteeetal.,2006).
Later we showed that K5 induces ubiquitination of Tetherin’s
cytosolic lysines, which leads to both its lysosomal degradation
and the enhancement of KSHV egress (Mansouri et al., 2009).
Other viruses, such as HIV-2 (Douglas et al., 2009; Le Tortorec
andNeil,2009),SIV(Jiaetal.,2009;Zhangetal.,2009),andEbola
(Kaletsky et al., 2009) also express antagonists of Tetherin, but
there is no evidence thus far to indicate that they utilize the UPS
for this function.
As discussed previously, adenoviruses express the E4orf6 and
E1B55k proteins that complex with cellular E3 Ub ligases to
degrade cellular proteins involved in apoptosis and cell cycle reg-
ulation. A recent proteomics study looking for new substrates of
E4orf6andE1B55k/Cul5foundnumeroushostproteinsthatwere
bothup-anddown-regulated.Oneof thesubstratesidentiﬁedwas
α3 integrin,which was degraded in the presence of theAdenoviral
proteins (Dallaire et al., 2009a). This same group showed that α3
integrin degradation promotes cell detachment from the extra-
cellular matrix and that this may contribute to viral release and
spreading (Dallaire et al.,2009b).
EVADING INNATE IMMUNE MECHANISMS
The interface between viruses and the host innate immune
responses has also provided numerous examples in which viruses
harness the UPS. IFN is the host’s ﬁrst line of defense against
viral infection and there are numerous examples in which viruses
employ the UPS to block either IFN production or its anti-viral
effects.Thefollowingsectionissub-dividedintothemainstepsof
the IFN pathway that are targeted by various viral classes, with an
emphasis on the most recent evidence for viral misappropriation
of the UPS to subvert anti-viral immunity (Table 4).
DOWNREGULATION OF FACTORS LEADING TO IFN PRODUCTION
The host cell has a variety of viral sensing mechanisms that
ultimately trigger IFN production (recently reviewed in Kan-
neganti, 2010). This signaling cascade begins with several classes
of pattern-recognition receptors (PRRs) including the Toll-like
receptors (TLRs), Retinoic acid inducible gene-I (RIG-I)-like
receptors (RLRs), and the nucleotide-binding oligomerization
domain (NOD)-like receptors (NLRs). Signaling through these
moleculesinturnleadstotheactivationofNF-κB,IRF3,andIRF7,
which promote IFNα/β expression. Many viruses have evolved
mechanismsthatutilizetheUPStodegradespeciﬁcplayerswithin
these pathways, thereby limiting IFN production.
Retinoic acid inducible gene-I
In an effort to inhibit IFN activation, inﬂuenza and HBV uti-
lize Ub-dependent mechanisms to target RIG-I either directly or
through its downstream effector the mitochondrial anti-viral sig-
naling protein (MAVS). In order to initiate the anti-viral signaling
cascade,RIG-ImustﬁrstbeubiquitinatedbytheE3ligasetripartite
motif(TRIM)protein25.TheinﬂuenzaNS1proteininteractswith
TRIM25, thereby preventing the ubiquitination of RIG-I. Gack
et al. (2009) suggest that NS1 works by blocking the oligomeriza-
tionof TRIM25,whichiscriticalforitsE3ligaseactivity.TheHBV
X protein (HBx) was recently found to inhibit IFN-β production
byinteractingwithMAVS,leadingtoitsubiquitinationandprotea-
somal degradation (Wei et al., 2010). One particular MAVS lysine
mutant exhibited increased IFN-β activation, suggesting that this
is the residue targeted for HBx-dependent ubiquitination. How-
ever, the particular E3 Ub ligase involved in this process has not
been identiﬁed.
IFN response factors
Other common viral targets degraded with the help of the UPS to
limit IFN production are IRF3 and IRF7. Examples can be found
amongtheﬂaviviruses,reoviruses,andherpesviruses.Bovineviral
diarrhea virus (BVDV) and classical swine fever virus (CSFV) are
ﬂaviviruses that encode NPro, a papain-like protease that acts as
an IFN antagonist by binding and inducing the polyubiquitina-
tion and subsequent degradation of IRF3 (Hilton et al., 2006;
Chen et al., 2007a). However, NPro protease activity does not
appear to be required for this function. Moreover, NPro from
CSFV was itself degraded in a UPS-dependent manner in the
absence of IRF3 (Seago et al., 2010) .W h e t h e rN P r oa c t sa saU b
ligase or recruits a cellular Ub ligase remains to be determined.
The rotavirus NSP1 protein has also been shown to block IFN
production by inducing the degradation of IRF3, IRF5, and IRF7
(reviewed in Sherry, 2009). Graff et al. (2007) showed that the
NSP1 zinc-binding domain is important for IRF3 degradation,
and their data suggests that NSP1 may be acting as an E3 Ub
ligase. Herpesviruses have also been shown to inhibit IFN activa-
tion by interfering with IRFs. As discussed above, the KSHV RTA
protein can function as both a transcriptional activator and an
E3 ligase. In addition to its other targets (see above), RTA also
induces the ubiquitination and degradation of IRF7 (Yu et al.,
2005). HSV encodes the multifunctional protein ICP0, which has
been shown to interfere with several stages of the IFN pathway,
including the prevention of IRF3 and IRF7 activation (reviewed
in Paladino and Mossman, 2009). ICP0 E3 Ub ligase activity has
been implicated in this function. However, recent data indicates
that inhibition of signal transducer and activator of transcrip-
tion (STAT) or IRF3 pathways does not enhance the replication
of ICP0-deletedviruses(Everett et al.,2008). These results suggest
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Table 4 | Evasion of the host immune system.
Immune
pathway
Viral protein Virus Ubiquitin function modiﬁed Reference
RIG-I NS1 Orthomyxo: inﬂuenza Interacts with E3 Ub ligase TRIM25, preventing
the ubiquitination of RIG-I
Gack et al. (2009)
X Hepadna: HBV Induces Ub and degradation of MAVS Wei et al. (2010)
NPro Flavivirus: BVDV and
CSFV
Induces Ub and degradation of IRF3 Hilton et al. (2006),
Chen et al. (2007a)
NSP1 Reo: rotavirus Induces the degradation of IRF3, IRF5, and IRF7 Reviewed in Sherry (2009)
IRFs RTA Herpes: KSHV Induces the ubiquitination and degradation of
IRF7
Yu et al. (2005)
ICP0 Herpes: HSV ICP0 E3 Ub ligase activity may prevent IRF3 and
IRF7 activation
Everett and Orr (2009),
Paladino and Mossman (2009)
Vif and Vpr Retro: HIV-1 Induces the Ub and degradation of IRF3 Okumura et al. (2008)
NF-κB NSP1 Reo: rotavirus Induces the Ub and degradation of βTrCP , which
in turn regulates NF-κB activation
Graff et al. (2009)
CP77 Pox: cowpox Blocks the nuclear translocation of NF-κB Chang et al. (2009)
P Paramyxo: measles Transcriptionally upregulates DUB A20, which
inhibits NF-κB activation
Yokota et al. (2008)
Unknown Orthomyxo: inﬂuenza Onose et al. (2006)
Core Flavivirus: Hepatitis C Nguyen et al. (2006)
ICP0 Herpes: HSV Interacts with and redirects DUB USP7 to the
cytoplasm where it binds and deubiquitinates
TRAF6
Daubeuf et al. (2009)
STATs NS5 Flavivirus: dengue Induces Ub and degradation of STAT2 Ashour et al. (2009)
Paramyxo: HPIV2 Complexes with DDB1/Cul4a E3 Ub ligase, lead-
ing to Ub and degradation of STAT2
Parisien et al. (2002)
V Paramyxo: PIV5 Complexes with DDB1/Cul4a E3 Ub ligase, lead-
ing to Ub and degradation of STAT1
Didcock et al. (1999)
Paramyxo: mumps Complexes with DDB1/Cul4a E3 Ub ligase, lead-
ing to Ub and degradation of STAT1 and STAT3
Ulane et al. (2003)
NS1 and NS2 Paramyxo: RSV Complexes with Cul2/ElonginC E3 Ub ligase,
leading to Ub and degradation of STAT2
Spann et al. (2004),
Elliott et al. (2007)
MHC-1 andT-cell
activation
markers
US2 and US11 Herpes: HCMV Targets MHC-1 for ERAD Wiertz et al. (1996a,b)
K3 and K5 Herpes: KSHV E3 Ub ligase activity induces Ub and lysosomal
degradation of MHC-1, CD1d and IFNγ; K5 also
inducesdegradationofICAM,B7 .2,MICA,MICB,
and AICL
Coscoy and Ganem (2000, 2001),
Ishido et al. (2000b),
Sanchez et al. (2005), Li et al. (2007),
Thomas et al. (2008)
mk3 Herpes: MHV68 E3UbligaseactivityinducesUbandproteasomal
degradation of MHC-1
Stevenson et al. (2000),
Boname and Stevenson (2001)
M153R Pox: myxoma E3 Ub ligase activity induces Ub and degradation
of CD4 and MHC-1
Mansouri et al. (2003)
E5 Papilloma Downregulates MHC-1 and CD1d, possibly
through interaction with calnexin
Gruener et al. (2007),
Miura et al. (2010)
APOBEC Vif Retro: HIV-1 Interacts with E3 Ub ligase Cul5/ElonginBC/Rbx1
to induce Ub and proteasomal degradation of
APOBEC3G and 3F
Marin et al. (2003), Sheehy et al.
(2003),Yu et al. (2003)
ICP0 Herpes: HSV E3UbligaseactivityinducesUbandproteasomal
degradation of PML and SP100
Boutell et al. (2002),
Gu and Roizman (2009)
PML disruption EBNA1 Herpes: EBV Induces degradation of PML through interaction
with DUB, USP7 and protein kinase, CK2
Sivachandran et al. (2010)
pp71 Herpes: HCMV Induces proteasomal degradation of Daxx, per-
haps via sumoylation
Saffert and Kalejta (2006),
Hwang and Kalejta (2009)
E1B55k Adeno: Ad5 InducesUbandproteasomaldegradationofDaxx Schreiner et al. (2010)
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that ICP0’s role in subversion of the IFN response may be sec-
ondary to its involvement in promyelocytic leukemia (PML) and
sp100degradation(seebelow;EverettandOrr,2009).Lastly,HIV-
1 has been shown to downregulate IRF3 protein levels in infected
cells,andOkumuraetal.(2008)haveprovidedevidencethatthisis
duetotheactionof theHIV-1E3UbadaptorproteinsVif andVpr
(Okumura et al.,2008). However,while ectopically expressedVpr
and Vif were shown to induce IRF3 ubiquitination and degrada-
tion in transfected 293T cells,IRF3 degradation was still observed
in T-cells infected with an HIV-1 vpr/vif double mutant. Recent
work from another group has conﬁrmed IRF3 downregulation by
HIV-1, and while their data supported a signiﬁcant role for Vpr
in that process,Vif did not appear to have an effect (Doehle et al.,
2009).
NF-κB
NF-κB activation provides yet another route to IFN production
and is thus a target for several viral antagonists. In addition to its
ability to degrade IRF3 (see above), the rotavirus NSP1 protein
also mediates the ubiquitination and degradation of the cellular
E3 Ub ligase F-box protein beta-transducin repeating contain-
ing protein (βTrCP), which regulates NF-κB activation via the
degradation of the NF-κB inhibitor IκB( Graff et al., 2009). This
provides an interesting example of a single virally encoded Ub
ligase targeting two separate mechanisms for IFN activation. The
cowpox host-range protein CP77 has also been found to inhibit
NF-κB activation. CP77 contains both an F-box motif that medi-
ates binding to the SCF complex and a series of ankyrin repeats
responsibleforbindingtoNF-κB.WhileitwasexpectedthatCP77
would simply serve as an adaptor targeting NF-κB for ubiquitina-
tion by the SCF complex, no CP77-dependent ubiquitination or
degradation of NF-κB was observed (Chang et al., 2009). Curi-
ously, both the CP77 F-box and ankyrin repeats are required in
ordertopreventNF-κBnucleartranslocation.BecauseNF-κBwas
not directly targeted for ubiquitination/degradation, the authors
propose that CP77 somehow sequesters NF-κB to prevent its acti-
vation and nuclear translocation (Chang et al., 2009). Measles
virus appears to exhibit a cell-type speciﬁc suppression of NF-
κB activation,which is active in monocytes but not epithelial cells
(Indohetal.,2007).ThisactivityismediatedbytheviralPprotein,
which has been shown to transcriptionally upregulate the cellular
DUBA20,thusleadingtotheinhibitionof NF-κB-dependentIFN
inductionviathedeubiquitinationof TRAF6(Yokotaetal.,2008).
As described in a previous section, A20 induction by EBV LMP1
was shown to inhibit IRF7, which consequently prevents IRF7-
dependent IFN induction (Ning and Pagano, 2010). Inﬂuenza
(Onoseetal.,2006)andhepatitisC(Nguyenetal.,2006)havealso
been shown to inactivate NF-κB via A20 induction. Therefore,
multiple viruses appear to utilize this cellular DUB as a means
to inhibit two separate IFN-induction pathways. Finally, HSV
appears to hijack a different cellular DUB to evade the immune
system.TheviraltranscriptionalactivatorICP0hasbeenshownto
interactwithandredirectthecellularDUBUSP7tothecytoplasm
where it deubiquitinates TRAF6 and IKKγ, which are required
for activation of the canonical NF-κB pathway (Daubeuf et al.,
2009).
DOWNREGULATION OF IFN SIGNALING MOLECULES (STATS)
OnceIFNisproduced,itbindstotheIFN-receptoronneighboring
cells,therebyactivatingtheSTATsignalingcascadethatultimately
results in the transcriptional activation of many anti-viral IFN-
stimulated genes (ISGs). This makes targeting STATs another
common means by which viruses ablate the IFN response. For
example, both the ﬂaviviruses and paramyxoviruses have evolved
UPS-dependent methods to eliminate STATs. The Dengue virus
NS5 polymerase interacts with STAT2, leading to STAT2 ubiqui-
tination and proteasome-dependent degradation. NS5 is initially
expressed as part of a single polyprotein that is cleaved by viral
and host proteases into more than 10 individual proteins. Inter-
estingly, NS5 alone can interact with STAT2, but does not induce
degradationexceptinthecontextof thepolyprotein(Ashouretal.,
2009).ItisnotknownwhetheracellularUbligaseisinvolvedorif
the proteolytic processing of the viral polyprotein somehow leads
to the degradation of STAT2. NS5 has also been shown to pre-
vent IFN-induced phosphorylation of STAT2, although this does
not appear to involve the UPS (Mazzon et al., 2009). The antag-
onism of IFN by paramyxoviruses is more complicated due to
the varied targeting of multiple STATs by different viral family
members. For example,among the rubulavirus genus,the human
parainﬂuenza type 2 (HPIV2) V protein directs the ubiquitina-
tion and degradation of STAT2 (Parisien et al., 2002), while the
PIV5V protein induces the degradation of STAT1 (Didcock et al.,
1999). In addition, the Mumps V protein targets both STAT1
and STAT3 (Ulane et al., 2003). Although the targets are var-
ied, it appears that the V proteins from these three viruses are
all able to form similar E3 Ub ligase complexes with DDB1 and
Cul4A, which are referred to as V protein-dependent degradation
complexes (VDC; Ulane and Horvath, 2002). Respiratory syncy-
tial virus (RSV), a paramyxovirus from the pneumovirus genus,
does not encode a V protein homolog. However STAT2 is still
degraded in a UPS-dependent manner that requires the viral NS1
andNS2proteins(Spannetal.,2004).Ithassincebeendiscovered
that the RSV NS1 protein interacts with ElonginC and Cul2 to
direct the ubiquitination and degradation of STAT2 (Elliott et al.,
2007).
DOWNREGULATION OF IFN-INDUCED PROTEINS
Interferon is responsible for activating many anti-viral genes.
Therefore, those viruses that fail to avoid early IFN signaling still
have many opportunities to circumvent downstream anti-viral
events.
MHC-1, MHC-like molecules, and T-cell activation markers
Themostwell-characterizedIFN-inducedanti-viraltargetknown
to be downregulated by many virus classes is MHC-1. The host
uses MHC-1 as a means to present viral antigens at the cell
surface for recognition by cytotoxic T-cells. In response, viruses
havedevelopednumerouswaystoevadethisimmunesurveillance
mechanism. Several members of the herpesvirus family have been
shown to usurp the UPS to downregulate MHC-1 and in some
cases T-cell activation markers from the cell surface. For example,
the HCMV US2 and US11 gene products act in the ER to tar-
getMHC-1forUb-dependentER-associateddegradation(ERAD;
Wiertz et al., 1996a,b). ERAD is normally used by the cell to
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eliminate misfolded proteins from the ER. US2 and US11 are
not Ub ligases. Instead, they target MHC-1 for dislocation from
the ER into the cytoplasm, where MHC-1 is then subjected to
proteasomal degradation. Interestingly, although both viral pro-
teins function similarly, they appear to interact with different Ub
ligases and translocation machinery complexes. Studies of US11-
mediated MHC-1 dislocation facilitated the initial identiﬁcation
of cellular components of the normal ERAD pathway, including
Derlin 1, SeL1L, VIMP, p97 ATPase, AUP1, and UbxD8 (Lilley
and Ploegh, 2004; Ye et al., 2004; Mueller et al., 2006, 2008). The
E3 Ub ligases associated with Derlin1 are HRD1 and gp78 (Lilley
and Ploegh, 2005), however it has not been conﬁrmed whether
these ligases are involved in the US11-mediated downregulation
of MHC-1.Incontrast,US2mediatesMHC-1dislocationthrough
interactionswiththesignalpeptidepeptidase(SPP;Loureiroetal.,
2006) and the E3 ligase TRC8 (translocation in renal carcinoma;
Staggetal.,2009).ThegammaherpesvirusesalsotargetMHC-1for
degradation,although they accomplish this task by encoding their
own E3 Ub ligases. KSHV encodes the E3 Ub ligases K3 and K5,
also known as modulators of immune recognition 1 and 2 (MIR1
and MIR2), respectively, which target MHC-1 for ubiquitina-
tion and subsequent lysosomal degradation (Coscoy and Ganem,
2000; Ishido et al., 2000b). Using a proteomics approach, several
groups have recently demonstrated that K5 decorates surface-
associated MHC-1 with a mixed-linkage ubiquitin chain, and
that this stimulates the Epsin1-dependent endocytosis and sub-
sequent lysosomal degradation of MHC-1 (Boname et al., 2010;
Goto et al., 2010). Although they are 40% homologous to one
another, K3 and K5 do not target the same molecules. K3 can
downregulate all classes of MHC-1, HLA-A, B, C, and E, while
K5 is speciﬁc for HLA-A and B (Ishido et al., 2000b). In con-
trast, K3 and K5 can each downregulate the IFNγ receptor (Li
et al., 2007). While the removal of MHC-1 from the cell sur-
face may be a good strategy to prevent cytotoxic T-cell killing,
it can also increase the likelihood of being targeted by NK cells,
which eliminate cells with low MHC-1 surface expression. The
differential targeting of MHC-1 molecules by K3 and K5 may be
one mechanism for the virus to block CTL killing without overtly
activating NK cells. In addition, K5 has been shown to downreg-
ulate ICAM-1 and B7.2, which are costimulatory molecules for
both T-cell and NK cell activation (Coscoy and Ganem, 2001),
thus preventing NK cell killing (Ishido et al., 2000a). To further
protect cells from NK cytotoxicity, K5 has also been shown to
downregulate the NKG2D ligands MHC class I-related chain A
(MICA),MICB,and the ligand for NKp80,activation-induced C-
type lectin (AICL; Thomas et al., 2008). CD1d, another NK and
T-cell activation marker, is downregulated by both K3 and K5,
which decreases CD1d-restricted T-cell activation (Sanchez et al.,
2005). MHV68,the mouse homolog of KSHV,only encodes mK3,
which has also been shown to downregulate MHC-1 (Stevenson
et al., 2000). However, instead of resulting in lysosomal MHC-1
degradation, mK3 appears to function in the ER via interaction
with the transporter associated with antigen processing protein
(TAP; Lybarger et al., 2003; Wang et al., 2005), thereby target-
ingMHC-1forproteasomaldegradation(BonameandStevenson,
2001). Similarly, the retroperitoneal ﬁbromatosis-associated her-
pesvirus (RFHV) also encodes a single K3/K5 homolog referred
to as rfK3, which appears to downregulate MHC-I and ICAM,
but not B7.2, in a Ub-dependent manner (Harris et al., 2010).
Members of the Poxviridae also encode their own Ub ligases. The
rabbitmyxomavirusM153RproteincontainsaRING-CHdomain
and appears to downregulate both MHC-1 and CD4 in a manner
reminiscent of MHC-1 downregulation by K3 and K5 (Mansouri
et al., 2003), suggesting a common immune evasion strategy for
the large DNA viruses.
The HPV E5 protein has recently been shown to downregu-
late the T-cell activation factor CD1d in a proteasome-dependent
manner.E5hasbeenproposedtoaccomplishthisbyinhibitingthe
calnexin-dependenttrafﬁckingofCD1d(Miuraetal.,2010).Inter-
estingly, E5 has also been demonstrated to downregulate MHC-1
(Ashraﬁ et al., 2005). However, this has been attributed to E5’s
interaction with the vacuolar ATPase, which leads to endosome
acidiﬁcation and retention of MHC-1 in the Golgi. This has also
been one of the proposed models for E5’s retention of EGF-R as
describedabove.However,likeCD1d,MHC-1alsobindstoE5and
calnexin in the ER,and E5 can only mediate MHC-1 downregula-
tion in calnexin-expressing cells (Gruener et al.,2007),suggesting
a potential role for the UPS in HPV’s immune evasion strategies.
An interesting caveat to emerge from the study of these viral
Ub ligases is their ability to target non-lysine residues for ubiq-
uitination. KSHV K3 ubiquitination of MHC-1 provided the ﬁrst
report of an E3 Ub ligase targeting a cysteine for ubiquitination
via a thioester linkage (Cadwell and Coscoy, 2005). Subsequent
studieshaverevealedthatK5alsotargetsMHC-1cysteineresidues
(CadwellandCoscoy,2008),andthatmK3conjugatesubiquitinto
MHC-1serineandthreonineresiduesviaesterbonds(Wangetal.,
2007). Interestingly, data from a recent mK3 study suggests that
while the RING-CH domain of these viral Ub ligases plays a role
in targeting non-lysine residues, sequences outside the RING-CH
domain are also required for this altered speciﬁcity (Herr et al.,
2009).
Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3
The apolipoprotein B mRNA editing enzyme catalytic
polypeptide-like 3 (APOBEC3) genes encode a family of cytidine
deaminases, several of which have been shown to be part of an
innate anti-retroviral defense that inhibits retroviral replication
(Sheehy et al., 2002). Of the family members, APOBEC3G and
3F appear to have the highest anti-viral activity. These enzymes
are incorporated into nascent virions where they subsequently
deaminate cytosines in the minus DNA strand generated via
reverse transcription. This action results in G to A transitions
in the genomic retroviral RNA, which leads to potentially lethal
nonsense and missense mutations.Aside from the“mutator”phe-
notype,somegroupshaveshownthatAPOBEC3mighthaveother
deleterious effects on the virus, as mutants without deaminase
activity still show anti-retroviral activity (reviewed in Neil and
Bieniasz, 2009). The lentiviral family of retroviruses express the
Vif accessory protein that counteracts this restriction by induc-
ing the ubiquitination and subsequent proteasomal degradation
of APOBEC3G (Marin et al., 2003; Sheehy et al., 2003). Vif har-
bors a unique SOCS-box motif that allows Vif to complex with
the Cul5/ElonginBC/Rbx1 E3 Ub ligase (Yu et al., 2003, 2004).
There is currently some debate as to whether Vif induces the
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direct ubiquitination of APOBEC (Iwatani et al., 2009)o ri f
Vif is itself ubiquitinated and acts as a suicide molecule that
delivers APOBEC to the proteasome (Dang et al., 2008). Most
recently, one group has demonstrated the Vif-dependent polyu-
biquitination of an APOBEC mutant devoid of lysine residues
(Shao et al., 2010). They later showed that in the absence of
lysines, the APOBEC N-terminal-MET residue is targeted for
ubiquitination (Wang et al., 2011). This same group has shown
that APOBEC degradation can occur without simultaneous Vif
degradation, weighing against a Vif suicide model (Shao et al.,
2010).
DISRUPTION OF THE PROMYELOCYTIC LEUKEMIA NUCLEAR BODIES
The PML protein was ﬁrst identiﬁed and named for its role in
acute promyelocytic leukemia (APL). The PML protein normally
aggregates with other proteins (Daxx, ATRX, SP100, and SUMO)
in the nucleus, forming distinct structures that have been shown
to be involved in many cellular functions, including cell cycle
regulation, DNA damage repair, apoptosis, transcriptional reg-
ulation, and IFN response to viral infection (see references in
Everett and Chelbi-Alix, 2007). APL results from a chromoso-
maltranslocationatthePMLlocus.Thisgivesrisetoapairof new
PML–retinoicacidreceptorfusionproteins,neitherofwhichallow
for the formation and assembly of functional PML NB (Melnick
and Licht, 1999). Herpesviruses and adenoviruses express pro-
teins that disrupt the PML NBs, thus preventing IFN-induced
anti-viral responses and resulting in enhanced viral transcrip-
tion and replication (reviewed in Everett and Chelbi-Alix, 2007).
For simplicity, we discuss all the examples of PML NB disrup-
tion in this section, although the impact that these have on viral
functions is varied. HSV-1 encodes ICP0, which induces the dis-
ruptionofPMLNBsviadegradationofthecomplexproteinsPML
and SP100. This degradation is proteasome dependent and relies
on the ICP0 RING domain E3 Ub ligase function (Boutell et al.,
2002; Gu and Roizman, 2009). EBV disrupts PML NBs through
the action of the viral transactivator EBNA1, in a process that
leadstothedevelopmentofnasopharyngealcarcinoma(Sivachan-
dranetal.,2008).ArecentstudysuggeststhatEBNA1’sdisruption
of PML NBs requires its interaction with host proteins includ-
ing the USP7 DUB and the CK2 protein kinase (Sivachandran
et al., 2010). The phosphorylation of PML by CK2 is impor-
tant for PML’s subsequent polyubiquitination and proteasomal
degradation (Scaglioni et al., 2008). Sivachandran et al. (2010)
hypothesize that EBNA1 enhances CK2’s effect on PML, but also
requiresUSP7bindingforcompletePMLNBdisruption.Therole
that USP7 plays here is not clear, given that its catalytic domain is
not required (Sivachandran et al., 2010). Daxx is a host-encoded
transcription repressor that can inhibit viral gene expression, and
is yet another PML NB component targeted for degradation by
viruses. The HCMV tegument protein pp71 induces the protea-
somal degradation of Daxx, thereby relieving the IFN-induced
inhibition on viral immediate early (IE) gene expression (Saffert
and Kalejta, 2006). While no cellular Ub ligase has been impli-
cated, data has been put forth suggesting that the pp71-mediated
degradation of Daxx (Hwang and Kalejta, 2007) may instead
involve SUMOylation (Hwang and Kalejta, 2009). However, a
Daxx mutant that is inefﬁciently SUMOylated was still degraded
bypp71andexhibitednodifferenceinIEgeneexpression(Hwang
and Kalejta, 2009). It has recently been shown that adenovirus
E1B55K also targets Daxx for ubiquitination and proteasomal
destruction (Schreiner et al., 2010). Schreiner et al. (2010) found
that knocking down Daxx via siRNA enhanced Ad5 replication,
and that unlike E1B55K’s other Ub-dependent functions, E4orf6
was not required.
UNKNOWN FUNCTIONS
There are many examples of virus-speciﬁc effects on the UPS that
we have not described here in detail because their advantage to
the virus has not yet been determined. However,we have included
them along with references in Table 5. It is expected that as these
“unknownfunctions”areresolved,theywillcontributetotheever-
increasing number of instances whereby viruses utilize the host
ubiquitin system (Table 5).
SUMMARY
Asthisreviewhashopefullymadeabundantlyclear,virusesdepend
upon ubiquitin at virtually all points within the lifecycle (see
Figure1).Theprevalenceofubiquitininnormalcellularprocesses
makes this unsurprising; by simply co-evolving with their hosts,
viruseshavehadtolearnto“speak”theubiquitinlanguageﬂuently
in order to maintain their high level of control in infected cells.
This can be accomplished via more or less elegant means; viruses
with limited coding capacity can utilize small adaptor proteins
to redirect or modify the activity of cellular ligases, while more
complex viruses can encode their own E3 ligases and DUBs. In
many cases, viral manipulation of ubiquitin is required to specif-
ically fend off host countermeasures, while in others ubiquitin
must be harnessed for viral replication functions. Additionally,
although we have focused on ubiquitin in this review, it is read-
ily apparent that viruses can manipulate the other ubiquitin-like
modiﬁers as well (see examples presented in Isaacson and Ploegh,
2009).
While much of the current ubiquitin literature has focused on
events involving lysine-targeted polyubiquitination of targets and
theirsubsequentdegradationviatheUPS,therecognitionthat(a)
non-lysine residues can be targeted and (b) that ubiquitination
itself comprises myriad different topological variants with a vast
array of non-degradation outcomes is already leading the ﬁeld to
cast a wider net regarding ubiquitin-dependent phenotypes. The
development of new proteomics tools (recently reviewed in Shi
et al., 2011) has greatly enhanced our ability to detect and study
these events, and such methods will in all likelihood continue to
improve.
Many of the current examples of viral manipulation of the
host ubiquitin system relate to aspects of innate immunity that
must be overcome, but it is clear that many cellular process that
are normally controlled by ubiquitin such as the cell cycle or the
MVB pathway can be readily reprogrammed to beneﬁt a virus.
This unfortunately does not provide many new drug-able tar-
gets,asalterationsmadetoanyexisting,ubiquitin-dependenthost
processes by small molecules will likely lead to other off-target
pathologies. However, in those situations where a viral adaptor
Frontiers in Microbiology | Cellular and Infection Microbiology July 2011 | Volume 2 | Article 161 | 14Gustin et al. Viral takeover of the host ubiquitin system
Cullin
Family
promote S-phase prevents DNA-damage response targets/impact unknown
enhanced viral
egress
inhibits NFκB
nuclear
translocation
inhibits NFκB
activation
counteracts 
macrophage-specific
restriction factor
activate antiviral
signaling
Ub
Ub PML
Ub Sp100
KSHV lytic
replication KSHV RTA
Hey1 Hey1
IRF7
IRF7
IRF7
IRF3
IRF5
K-RBP K-RBP
Ub
Ub
Ub
Ub
Ub
Ub
Ub
IRF7
Ub A20
=inactive
= active
= active
NFκB
= active
NFκB
= inactive
NFκB
= degrade
= inactive
NFκB
TRAF6
TRAF6
EBV LMP1
A20
USP7
Measles P
HCV core
Influenza ?
HSV ICP0
IKKγ IKKγ
Ub
Ub
Nedd8
Nedd8
CD4
Myxoma M153R
EBV latency
inhibit cell
death
Ub
EBV LMP2A
EBV LMP2A
cCbl
Ub
EBV lytic cycle
promotes viral
egress
nucleocapsid
transport
to nucleus
Ub
Lyn
Lyn
NEDD4
viral late
domains
Ub
HPV E6
E6-AP
p53
Ub
Ub
Ub
Ub
Ub
Ub
Ub
Ub
Ub
Ub MHCI (all)
HLA-A
HLA-B
IFNγ-R
CD1d
HLA-C
HLA-E
Ub BST2/Tetherin
ICAM-1
B7.2
MICA
MICB
Ub AICL
KSHV K5
RFHV K3
KSHV K3
inactivate antiviral
signaling
RIG-I
Ub RIG-I
MAVS
Ub MAVS
Influenza NS1
Rotavirus NSP1
Rotavirus NSP1
TRIM25 n TRIM25
Cul2
Cul1 Cul5
Cul4
Cul3
APC2
Pox ankyrin-like
MHV68
ORF73
Pox BTB-Kelch
HIV Vpr/SIV Vpx
RSV NS1
HPV E7
HBV X
HIV Vif
HIV Vpu
Pox PACR
HPIV2, 
PIV5 and 
Mumps
V proteins
Adeno
 E4orf6
Adeno 12
 E4orf6
Adenovirus
capsid VI
Adeno
E1B55k
EBV BPLF1
EBV BPLF1
Ub DNA ligase IV
MRN
p53
α3 integrin
Ub
Ub
Ub
STAT2
pRb
Ub TOPBP1
HPV E2
CyclinB+Skp2
stabilized
Ub STATs
Ub
APOBEC3G/F
RelA
DCAF
DDB1
Cdc20
Cdh1
APC11
EloB/C
Skp1
βTrCP
EloB/C
HECT family
FIGURE 1 |A schematic overview depicting examples of viral
interference with the host ubiquitin system. Included here are cases in
which either the E3 ligases or speciﬁc targets are known. With the exception
of the cellular DUBs shown in green, the Cullin proteins shown in purple, and
the various Cullin complex members shown in gold, cellular proteins are
shown in blue. All viral proteins are shown in red. Ub, ubiquitin.The box at the
top contains the relatively few cases in which HECT ligases are utilized.The
remainder of the examples shown depend upon RING-family ligases. In the
majority of cases shown, ubiquitination leads to degradation of the target
protein. When degradation is not the outcome, or when ubiquitination of
normal targets is prevented, the resulting phenotype has been annotated.
See main text for speciﬁc references.
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Table 5 | Role of UPS in unknown viral functions.
Viral protein Virus Ubiquitin function modiﬁed Reference
K5 Herpes: KSHV Induces Ub and degradation of ICAM in endothelial cells, which
may inhibitT-cell recruitment
Manes et al. (2010)
Induces Ub and degradation of CD31/PECAM-1 in endothelial
cells, which may affect adhesion and migration
Mansouri et al. (2006)
Induces Ub and degradation of ALCAM and Syntaxin-4 Bartee et al. (2006)
Induces Ub and lysosomal degradation of MHC-1 related mole-
cule, HFE, which may effect iron balance
Rhodes et al. (2010)
ICP0 Herpes: HSV E3 RING domain required for ICP0 incorporation into virions, and
subsequent post-entry delivery of virions to the nucleus
Delboy et al. (2010),
Delboy and Nicola (2011)
VP22 major tegument protein also required for ICP0 virion
incorporation
Maringer and Elliott (2010)
E3RINGdomainrequiredtodismantlemicrotubulenetworkmay
be involved in virion assembly or egress
Liu et al. (2010)
UL56 Induces Ub and subsequent relocalization of Nedd4 to vesicles Ushijima et al. (2008, 2009)
P28 Pox E3 Ub ligase activity targets Ub to viral replication factories Huang et al. (2004),
Nerenberg et al. (2005)
BTB-BACK-Kelch (BBK) Adaptors connecting Cul3 complexes to target substrates Wilton et al. (2008);
Shchelkunov (2010)
M148R, M149R, MNF
(Myxoma Nuclear
factor), and M-T5
Pox: myxoma Virulence factors that potentially modulate UPS Blanie et al. (2010)
EVM002, EVM005,
EVM154, and EVM165
Pox: ectromelia F-box proteins; EVM002 interacts with E3 Ub ligase
Skp1/Cul1/Roc1
Van Buuren et al. (2008)
PLPro Coronavirus: SARS DUB activity removes Ub and ISG15 from proteins, separable
from IFN antagonism function
Clementz et al. (2010)
Rep Parvovirus: AAV Rep proteins Ub and possible degradation by Ad5
E4orf6/E1B55k/Cul5 E3 ligase complex
Nayak et al. (2008),
Farris et al. (2010)
Orf3 Circovirus: porcine Interacts with PirH2 E3 Ub ligase, preventing interaction with
p53, thus leading to apoptosis
Liu et al. (2007),
Karuppannan et al. (2010)
Vpr Retro: HIV-1 Interacts with DCAF1/DDB1/Cul4 E3 Ub ligase, inducing Ub and
proteasomal degradation of the uracil-DNA glycosylase UNG2
Ahn et al. (2010)
protein is used to link a host protein to a Ub-ligase complex, the
physical interface between the viral protein and the host protein
may provide us with an interaction that can safely be inhibited
or prevented. In the near term, the catalytic sites of the virally
encoded DUBs present the most attractive therapeutic targets and
they are in fact the subject of intense investigation by numerous
groups (Chen et al., 2007b, 2009; Ratia et al., 2008; Ghosh et al.,
2010).
REFERENCES
Ahn, J., Vu, T., Novince, Z., Guerrero-
Santoro,J.,Rapic-Otrin,V.,andGro-
nenborn, A. M. (2010). HIV-1 Vpr
loads uracil DNA glycosylase-2 onto
DCAF1,asubstraterecognitionsub-
unit of a cullin 4A-RING E3 ubiqui-
tin ligase for proteasome-dependent
degradation. J. Biol. Chem. 285,
37333–37341.
Aravind, L., and Koonin, E. V.
(2000). The U box is a modiﬁed
RING ﬁnger–ac o m m o nd o main
in ubiquitination. Curr. Biol. 10,
R132–R134.
Ashour, J., Laurent-Rolle, M., Shi, P. Y.,
and Garcia-Sastre,A. (2009). NS5 of
dengue virus mediates STAT2 bind-
ing and degradation. J. Virol. 83,
5408–5418.
Ashraﬁ,G. H.,Haghshenas,M. R.,Mar-
chetti,B.,O’Brien,P.M.,andCampo,
M. S. (2005). E5 protein of human
papillomavirus type 16 selectively
downregulates surface HLA class I.
Int. J. Cancer 113, 276–283.
Ayinde, D., Maudet, C., Transy, C., and
Margottin-Goguet, F. (2010). Lime-
lightontwoHIV/SIVaccessorypro-
teins in macrophage infection: is
Vpx overshadowingVpr? Retrovirol-
ogy 7, 35.
Bandi, P., Garcia, M. L., Booth, C. J.,
Chisari, F. V., and Robek, M. D.
(2010). Bortezomib inhibits hepati-
tis B virus replication in transgenic
mice.Antimicrob.Agents Chemother.
54, 749–756.
Banks, L., Pim, D., and Thomas,
M. (2003). Viruses and the 26S
proteasome: hacking into destruc-
tion. Trends Biochem. Sci. 28, 452–
459.
Bartee, E., Mccormack, A., and Fruh,
K. (2006). Quantitative membrane
proteomics reveals new cellular tar-
gets of viral immune modula-
tors. PLoS Pathog. 2, e107. doi:
10.1371/journal.ppat.0020107
Basler, M., Lauer, C., Beck, U., and
Groettrup, M. (2009). The pro-
teasome inhibitor bortezomib
enhances the susceptibility to
viral infection. J. Immunol. 183,
6145–6150.
Bellanger, S., Blachon, S., Mechali, F.,
Bonne-Andrea, C., and Thierry, F.
(2005). High-risk but not low-risk
HPV E2 proteins bind to the APC
activators Cdh1 and Cdc20 and
cause genomic instability. Cell Cycle
4, 1608–1615.
Bellanger,S.,Tan,C.L.,Nei,W.,He,P.P.,
and Thierry, F. (2010). The human
papillomavirus type 18 E2 protein is
a cell cycle-dependent target of the
SCFSkp2 ubiquitin ligase. J. Virol.
84, 437–444.
Bernal,J.A.,Luna,R.,Espina,A.,Lazaro,
I., Ramos-Morales, F., Romero, F.,
Arias,C.,Silva,A.,Tortolero,M.,and
Pintor-Toro, J. A. (2002). Human
securin interacts with p53 and mod-
ulates p53-mediated transcriptional
activity and apoptosis. Nat. Genet.
32, 306–311.
Bienz, M. (2006). The PHD ﬁn-
ger, a nuclear protein-interaction
domain. Trends Biochem. Sci. 31,
35–40.
Frontiers in Microbiology | Cellular and Infection Microbiology July 2011 | Volume 2 | Article 161 | 16Gustin et al. Viral takeover of the host ubiquitin system
Blackford, A. N., Patel, R. N., Forrester,
N. A., Theil, K., Groitl, P., Stew-
art, G. S., Taylor, A. M., Morgan,
I. M., Dobner, T., Grand, R. J., and
Turnell, A. S. (2010). Adenovirus
12 E4orf6 inhibits ATR activation
bypromotingTOPBP1degradation.
Proc. Natl. Acad. Sci. U.S.A. 107,
12251–12256.
Blanchette, P., and Branton, P. E.
(2009). Manipulation of the
ubiquitin-proteasome pathway by
small DNA tumor viruses. Virology
384, 317–323.
Blanchette, P., Kindsmuller, K., Groitl,
P.,Dallaire,F.,Speiseder,T.,Branton,
P. E., and Dobner, T. (2008). Con-
trol of mRNA export by adenovirus
E4orf6 and E1B55K proteins during
productiveinfectionrequiresE4orf6
ubiquitin ligase activity. J. Virol. 82,
2642–2651.
Blanie, S., Gelﬁ, J., Bertagnoli, S.,
andCamus-Bouclainville,C.(2010).
MNF, an ankyrin repeat protein of
myxoma virus, is part of a native
cellular SCF complex during viral
infection. Virol. J. 7, 56.
Boname, J. M., and Stevenson, P. G.
(2001). MHC class I ubiquitination
by a viral PHD/LAP ﬁnger protein.
Immunity 15, 627–636.
Boname, J. M., Thomas, M., Stagg, H.
R., Xu, P., Peng, J., and Lehner,
P. J. (2010). Efﬁcient internaliza-
tion of MHC I requires lysine-
11 and lysine-63 mixed linkage
polyubiquitin chains. Trafﬁc 11,
210–220.
Bottcher, S., Maresch, C., Granzow,
H., Klupp, B. G., Teifke, J. P., and
Mettenleiter, T. C. (2008). Muta-
genesis of the active-site cysteine
in the ubiquitin-speciﬁc protease
contained in large tegument pro-
tein pUL36 of pseudorabies virus
impairs viral replication in vitro and
neuroinvasion in vivo. J. Virol. 82,
6009–6016.
Bour, S., Perrin, C., and Strebel, K.
(1999). Cell surface CD4 inhibits
HIV-1 particle release by interfering
withVpu activity. J. Biol. Chem. 274,
33800–33806.
Boutell, C., Sadis, S., and Everett, R. D.
(2002). Herpes simplex virus type 1
immediate-earlyproteinICP0andis
isolated RING ﬁnger domain act as
ubiquitin E3 ligases in vitro. J. Virol.
76, 841–850.
Boyer, S. N., Wazer, D. E., and Band, V.
(1996). E7 protein of human papil-
loma virus-16 induces degradation
of retinoblastoma protein through
the ubiquitin-proteasome pathway.
Cancer Res. 56, 4620–4624.
Breitschopf, K., Bengal, E., Ziv, T.,
Admon, A., and Ciechanover, A.
(1998). A novel site for ubiquitina-
tion:theN-terminalresidue,andnot
internal lysines of MyoD,is essential
for conjugation and degradation of
theprotein.EMBOJ.17,5964–5973.
Bres, V., Kiernan, R. E., Linares, L.
K., Chable-Bessia, C., Plechakova,
O., Treand, C., Emiliani, S., Pelo-
ponese, J. M., Jeang, K. T., Coux,
O.,Scheffner,M.,and Benkirane,M.
(2003). A non-proteolytic role for
ubiquitin in Tat-mediated transacti-
vation of the HIV-1 promoter. Nat.
Cell Biol. 5, 754–761.
Bres,V.,Yoshida,T.,Pickle,L.,andJones,
K. A. (2009). SKIP interacts with
c-Myc and Menin to promote HIV-
1 Tat transactivation. Mol. Cell 36,
75–87.
Burroughs, A. M., Balaji, S., Iyer, L.
M., and Aravind, L. (2007). Small
butversatile:theextraordinaryfunc-
tional and structural diversity of the
beta-grasp fold. Biol. Direct 2, 18.
Cadwell, K., and Coscoy, L. (2005).
Ubiquitination on nonlysine
residues by a viral E3 ubiquitin
ligase. Science 309, 127–130.
Cadwell, K., and Coscoy, L. (2008). The
speciﬁcities of Kaposi’s sarcoma-
associated herpesvirus-encoded E3
ubiquitin ligases are determined by
the positions of lysine or cysteine
residueswithintheintracytoplasmic
domains of their targets. J. Virol. 82,
4184–4189.
Calistri, A., Salata, C., Parolin, C., and
Palu, G. (2009). Role of multivesic-
ular bodies and their components in
theegressof envelopedRNAviruses.
Rev. Med. Virol. 19, 31–45.
Calistri, A., Sette, P., Salata, C., Cancel-
lotti, E., Forghieri, C., Comin, A.,
Gottlinger, H., Campadelli-Fiume,
G., Palu, G., and Parolin, C. (2007).
Intracellulartrafﬁckingandmatura-
tionofHerpessimplexvirus type1gB
and virus egress require functional
biogenesis of multivesicular bodies.
J. Virol. 81, 11468–11478.
Carson, C. T., Orazio, N. I., Lee, D. V.,
Suh, J., Bekker-Jensen, S., Araujo, F.
D., Lakdawala, S. S., Lilley, C. E.,
Bartek, J., Lukas, J., and Weitzman,
M. D. (2009). Mislocalization of the
MRN complex prevents ATR sig-
naling during adenovirus infection.
EMBO J. 28, 652–662.
Carson, C. T., Schwartz, R. A., Stracker,
T. H., Lilley, C. E., Lee, D. V., and
Weitzman,M. D. (2003). The Mre11
complex is required for ATM acti-
vation and the G2/M checkpoint.
EMBO J. 22, 6610–6620.
Casey, L., Wen, X., and De Noronha,
C. M. (2010). The functions of the
HIV1 protein Vpr and its action
through the DCAF1.DDB1.Cullin4
ubiquitin ligase. Cytokine 51, 1–9.
Chang, H. S., Lin, C. H., Yang, C.
H., Liang, Y. J., and Yu, W. C.
(2010). The human papillomavirus-
16 (HPV-16) oncoprotein E7 conju-
gates with and mediates the role of
the transforming growth factor-beta
inducible early gene 1 (TIEG1) in
apoptosis. Int. J. Biochem. Cell Biol.
42, 1831–1839.
Chang, S. J., Hsiao, J. C., Sonnberg, S.,
Chiang, C. T., Yang, M. H., Tzou,
D. L., Mercer, A. A., and Chang, W.
(2009). Poxvirus host range protein
CP77containsanF-box-likedomain
that is necessary to suppress NF-
kappaBactivationbytumornecrosis
factor alpha but is independent of
its host range function. J. Virol. 83,
4140–4152.
Chen, B. J., and Lamb, R. A. (2008).
Mechanisms for enveloped virus
budding: can some viruses do
without an ESCRT? Virology 372,
221–232.
Chen, C., and Zhuang, X. (2008). Epsin
1 is a cargo-speciﬁc adaptor for
the clathrin-mediated endocytosis
of the inﬂuenza virus. Proc. Natl.
Acad. Sci. U.S.A. 105, 11790–11795.
Chen, X., Chou, C. Y., and Chang,
G. G. (2009). Thiopurine analogue
inhibitors of severe acute respira-
tory syndrome-coronavirus papain-
like protease, a deubiquitinating
and deISGylating enzyme. Antivir.
Chem. Chemother. 19, 151–156.
Chen, Z., Rijnbrand, R., Jangra, R. K.,
Devaraj,S.G.,Qu,L.,Ma,Y.,Lemon,
S. M., and Li, K. (2007a). Ubiqui-
tination and proteasomal degrada-
tionofinterferonregulatoryfactor-3
induced by Npro from a cytopathic
bovine viral diarrhea virus. Virology
366, 277–292.
Chen,Z.,Wang,Y.,Ratia,K.,Mesecar,A.
D.,Wilkinson,K.D.,andBaker,S.C.
(2007b). Proteolytic processing and
deubiquitinating activity of papain-
like proteases of human coronavirus
NL63. J. Virol. 81, 6007–6018.
Cheng, C. Y., Gilson, T., Dallaire,
F., Ketner, G., Branton, P. E.,
and Blanchette, P. (2010). The
E4orf6/E1B55K E3 ubiquitin ligase
complexes of human adenoviruses
exhibit heterogenity in composition
and substrate speciﬁcity. J. Virol. 85,
765–775.
Chiari, E., Lamsoul, I., Lodewick, J.,
Chopin, C., Bex, F., and Pique,
C. (2004). Stable ubiquitination
of human T-cell leukemia virus
type 1 tax is required for pro-
teasome binding. J. Virol. 78,
11823–11832.
Ciancanelli, M. J., and Basler, C.
F. (2006). Mutation of YMYL in
the Nipah virus matrix protein
abrogates budding and alters sub-
cellular localization. J. Virol. 80,
12070–12078.
Clementz, M. A., Chen, Z., Banach, B.
S.,Wang,Y., Sun, L., Ratia, K., Baez-
Santos, Y. M., Wang, J., Takayama,
J., Ghosh, A. K., Li, K., Mesecar, A.
D., and Baker, S. C. (2010). Deu-
biquitinating and interferon antag-
onism activities of coronavirus
papain-like proteases. J. Virol. 84,
4619–4629.
Coscoy, L., and Ganem, D. (2000).
Kaposi’s sarcoma-associated her-
pesvirus encodes two proteins that
block cell surface display of MHC
class I chains by enhancing their
endocytosis. Proc. Natl. Acad. Sci.
U.S.A. 97, 8051–8056.
Coscoy, L., and Ganem, D. (2001). A
viral protein that selectively down-
regulates ICAM-1 and B7-2 and
modulates T cell costimulation. J.
Clin. Invest. 107, 1599–1606.
Craven, R. C., Harty, R. N., Para-
gas, J., Palese, P., and Wills, J. W.
(1999). Late domain function iden-
tiﬁedinthevesicularstomatitisvirus
M protein by use of rhabdovirus-
retrovirus chimeras. J. Virol. 73,
3359–3365.
Crump, C. M., Yates, C., and Min-
son, T. (2007). Herpes simplex virus
type 1 cytoplasmic envelopment
requiresfunctionalVps4.J.Virol.81,
7380–7387.
Dallaire, F., Blanchette, P., and Bran-
ton, P. E. (2009a). A proteomic
approach to identify candidate sub-
stratesofhumanadenovirusE4orf6-
E1B55K and other viral cullin-based
E3 ubiquitin ligases. J. Virol. 83,
12172–12184.
Dallaire, F., Blanchette, P., Groitl, P.,
Dobner, T., and Branton, P. E.
(2009b). Identiﬁcation of integrin
alpha3 as a new substrate of the ade-
novirus E4orf6/E1B 55-kilodalton
E3 ubiquitin ligase complex. J.Virol.
83, 5329–5338.
Dang, Y., Siew, L. M., and Zheng, Y. H.
(2008). APOBEC3G is degraded by
the proteasomal pathway in a Vif-
dependent manner without being
polyubiquitylated. J. Biol. Chem.
283, 13124–13131.
Daubeuf, S., Singh, D., Tan, Y., Liu,
H., Federoff, H. J., Bowers, W. J.,
and Tolba, K. (2009). HSV ICP0
recruits USP7 to modulate TLR-
mediated innate response. Blood
113, 3264–3275.
Davies, B. A., Lee, J. R., Oestreich,
A. J., and Katzmann, D. J. (2009).
Membrane protein targeting to the
MVB/lysosome. Chem. Rev. 109,
1575–1586.
www.frontiersin.org July 2011 | Volume 2 | Article 161 | 17Gustin et al. Viral takeover of the host ubiquitin system
DeHart, J. L., Bosque, A., Harris, R.
S., and Planelles, V. (2008). Human
immunodeﬁciency virus type 1 Vif
induces cell cycle delay via recruit-
mentof thesameE3ubiquitinligase
complexthattargetsAPOBEC3pro-
teins for degradation. J. Virol. 82,
9265–9272.
Delboy,M. G.,and Nicola,A.V. (2011).
A pre-immediate early role for tegu-
ment ICP0 in the proteasome-
dependent entry of Herpes simplex
virus. J. Virol. 85, 5910–5918.
Delboy,M. G.,Roller,D. G.,and Nicola,
A. V. (2008). Cellular proteasome
activity facilitates Herpes simplex
virus entryatapostpenetrationstep.
J. Virol. 82, 3381–3390.
Delboy, M. G., Siekavizza-Robles, C. R.,
andNicola,A.V.(2010).Herpessim-
plex virus tegument ICP0 is capsid
associated, and its E3 ubiquitin lig-
ase domain is important for incor-
poration into virions. J. Virol. 84,
1637–1640.
Demers, G. W., Halbert, C. L., and
Galloway, D. A. (1994). Elevated
wild-type p53 protein levels in
human epithelial cell lines immor-
talizedbythehumanpapillomavirus
type 16 E7 gene. Virology 198,
169–174.
Deshaies, R. J., and Joazeiro, C. A. P.
(2009). RING domain E3 ubiqui-
tin ligases. Ann. Rev. Biochem. 78,
399–434.
Didcock, L., Young, D. F., Good-
bourn, S., and Randall, R. E. (1999).
The V protein of simian virus
5 inhibits interferon signalling by
targeting STAT1 for proteasome-
mediated degradation. J. Virol. 73,
9928–9933.
Dikic, I., Wakatsuki, S., and Wal-
ters, K. J. (2009). Ubiquitin-binding
domains – from structures to func-
tions. Nat. Rev. Mol. Cell Biol. 10,
659–671.
Doehle, B. P., Hladik, F., Mcnevin,
J. P., Mcelrath, M. J., and Gale,
M. Jr. (2009). Human immun-
odeﬁciency virus type 1 mediates
global disruption of innate antivi-
ral signaling and immune defenses
within infected cells. J. Virol. 83,
10395–10405.
Douglas, J. L., Gustin, J. K.,
Viswanathan, K., Mansouri,
M., Moses, A. V., and Fruh, K.
(2010). The great escape: viral
strategiestocounterBST-2/tetherin.
PLoS Pathog. 6, e1000913. doi:
10.1371/journal.ppat.1000913
Douglas, J. L., Viswanathan, K., Mccar-
roll, M. N., Gustin, J. K., Fruh, K.,
and Moses,A.V. (2009).Vpu directs
the degradation of the human
immunodeﬁciency virus restric-
tion factor BST-2/Tetherin via a
betaTrCP-dependent mechanism. J.
Virol. 83, 7931–7947.
Downs, J. A., and Jackson, S. P. (2004).
A means to a DNA end: the many
roles of Ku. Nat. Rev. Mol. Cell Biol.
5, 367–378.
Dul, B. E., and Walworth, N. C. (2007).
The plant homeodomain ﬁngers of
ﬁssionyeastMsc1exhibitE3ubiqui-
tin ligase activity. J. Biol. Chem. 282,
18397–18406.
Eichler, R., Strecker, T., Kolesnikova,
L., Ter Meulen, J., Weissenhorn, W.,
Becker, S., Klenk, H. D., Garten, W.,
and Lenz, O. (2004). Characteriza-
tion of the Lassa virus matrix pro-
teinZ:electronmicroscopicstudyof
virus-like particles and interaction
with the nucleoprotein (NP). Virus
Res. 100, 249–255.
Elliott, J., Lynch, O. T., Suessmuth,
Y., Qian, P., Boyd, C. R., Burrows,
J. F., Buick, R., Stevenson, N. J.,
Touzelet, O., Gadina, M., Power, U.
F., and Johnston, J. A. (2007). Res-
piratory syncytial virus NS1 pro-
tein degrades STAT2 by using the
Elongin-Cullin E3 ligase. J.Virol. 81,
3428–3436.
Everett, R. D., and Chelbi-Alix, M. K.
(2007). PML and PML nuclear bod-
ies:implicationsinantiviraldefence.
Biochimie 89, 819–830.
Everett, R. D., and Orr, A. (2009).
Herpes simplex virus t y p e1r e g u -
latory protein ICP0 aids infection
in cells with a preinduced inter-
feron response but does not impede
interferon-induced gene induction.
J. Virol. 83, 4978–4983.
Everett, R. D., Young, D. F., Randall, R.
E., and Orr, A. (2008). STAT-1- and
IRF-3-dependent pathways are not
essential for repression of ICP0-null
mutant Herpes simplex virus type 1
in human ﬁbroblasts. J. Virol. 82,
8871–8881.
Farris, K. D., Fasina, O., Sukhu, L., Li,
L., and Pintel, D. J. (2010). Adeno-
associated virus small rep proteins
are modiﬁed with at least two types
of polyubiquitination. J. Virol. 84,
1206–1211.
Gack, M. U., Albrecht, R. A., Urano, T.,
Inn, K. S., Huang, I. C., Carnero,
E., Farzan, M., Inoue, S., Jung, J.
U., and Garcia-Sastre, A. (2009).
Inﬂuenza A virus NS1 targets the
ubiquitin ligase TRIM25 to evade
recognition by the host viral RNA
sensor RIG-I. Cell Host Microbe 5,
439–449.
Garcia,M.L.,Byﬁeld,R.,andRobek,M.
D. (2009). Hepatitis B virus replica-
tion and release are independent of
core lysine ubiquitination. J. Virol.
83, 4923–4933.
Gastaldello, S., Hildebrand, S., Fari-
dani, O., Callegari, S., Palmkvist,
M., Di Guglielmo, C., and Masucci,
M. G. (2010). A deneddylase
encoded by Epstein-Barr virus pro-
motes viral DNA replication by
regulating the activity of cullin-
RING ligases. Nat. Cell Biol. 12,
351–361.
Ghosh, A. K., Takayama, J., Rao, K. V.,
Ratia, K., Chaudhuri, R., Mulhearn,
D. C., Lee, H., Nichols, D. B., Bal-
iji, S., Baker, S. C., Johnson, M.
E., and Mesecar, A. D. (2010).
Severe acute respiratory syndrome
coronavirus papain-like novel pro-
tease inhibitors: design, synthesis,
protein-ligand X-ray structure and
biological evaluation. J. Med. Chem.
53, 4968–4979.
Gofﬁnet, C., Allespach, I., Homann,
S., Tervo, H. M., Habermann, A.,
Rupp, D., Oberbremer, L., Kern,
C., Tibroni, N., Welsch, S., Krijnse-
Locker, J., Banting, G., Krausslich,
H. G., Fackler, O. T., and Kep-
pler, O. T. (2009). HIV-1 antago-
nism of CD317 is species speciﬁc
and involves Vpu-mediated protea-
somal degradation of the restric-
tion factor. Cell Host Microbe 5,
285–297.
Gonzalez, C. M., Wang, L., and Dama-
nia, B. (2009). Kaposi’s sarcoma-
associated herpesvirus encodes a
viral deubiquitinase. J. Virol. 83,
10224–10233.
Goto, E., Yamanaka, Y., Ishikawa, A.,
Aoki-Kawasumi, M., Mito-Yoshida,
M., Ohmura-Hoshino, M., Mat-
suki, Y., Kajikawa, M., Hirano, H.,
and Ishido, S. (2010). Contribu-
tion of Lysine 11-linked Ubiqui-
tination to MIR2-mediated major
histocompatibility complex class I
internalization. J. Biol. Chem. 285,
35311–35319.
Gottwein, E., Jager, S., Habermann,
A., and Krausslich, H. G. (2006).
Cumulative mutations of ubiquitin
acceptor sites in human immun-
odeﬁciency virus type 1 gag cause
a late budding defect. J. Virol. 80,
6267–6275.
Gould, F., Harrison, S. M., Hewitt,
E. W., and Whitehouse, A. (2009).
Kaposi’s sarcoma-associated her-
pesvirus RTA promotes degrada-
tion of the Hey1 repressor protein
through the ubiquitin proteasome
pathway. J. Virol. 83, 6727–6738.
Grabbe, C., and Dikic, I. (2009).
Functional roles of ubiquitin-like
domain (ULD) and ubiquitin-
binding domain (UBD) contain-
ing proteins. Chem. Rev. 109,
1481–1494.
Graff, J. W., Ettayebi, K., and Hardy, M.
E. (2009). Rotavirus NSP1 inhibits
NFkappaB activation by inducing
proteasome-dependent degradation
of beta-TrCP: a novel mechanism
of IFN antagonism. PLoS Pathog.
5, e1000280. doi: 10.1371/jour-
nal.ppat.1000280
Graff, J. W., Ewen, J., Ettayebi, K., and
Hardy, M. E. (2007). Zinc-binding
domain of rotavirus NSP1 is
required for proteasome-dependent
degradationofIRF3andautoregula-
tory NSP1 stability. J. Gen. Virol. 88,
613–620.
Gredmark-Russ, S., Isaacson, M. K.,
Kattenhorn, L., Cheung, E. J., Wat-
son, N., and Ploegh, H. L. (2009).
A gammaherpesvirus ubiquitin-
speciﬁc protease is involved in the
establishment of murine gamma-
herpesvirus 68 infection. J.Virol. 83,
10644–10652.
Gruener, M., Bravo, I. G., Mom-
burg, F., Alonso, A., and Tomakidi,
P. (2007). The E5 protein of
the human papillomavirus type
16 down-regulates HLA-I surface
expression in calnexin-expressing
but not in calnexin-deﬁcient cells.
Virol. J. 4, 116.
Gu,H.,andRoizman,B.(2009).Thetwo
functions of Herpes simplex virus 1
ICP0, inhibition of silencing by the
CoREST/REST/HDAC complex and
degradation of PML,are executed in
tandem. J. Virol. 83, 181–187.
Harhaj, N. S., Sun, S. C., and Harhaj, E.
W.(2007).Activationof NF-kappaB
by the human T cell leukemia virus
type I Tax oncoprotein is associ-
ated with ubiquitin-dependent relo-
calizationof IkappaBkinase.J.Biol.
Chem. 282, 4185–4192.
Harris, S., Lang, S. M., and Means,
R. E. (2010). Characterization of
the rhesus ﬁbromatosis herpesvirus
MARCHfamilymemberrfK3.Virol-
ogy 398, 214–223.
Harty, R. N., Brown, M. E., Mcget-
tigan, J. P., Wang, G., Jayakar,
H. R., Huibregtse, J. M., Whitt,
M. A., and Schnell, M. J. (2001).
Rhabdoviruses and the cellular
ubiquitin-proteasome system: a
budding interaction. J. Virol. 75,
10623–10629.
Harty, R. N., Brown, M. E., Wang,
G., Huibregtse, J., and Hayes, F. P.
(2000). A PPxY motif within the
VP40 protein of Ebola virus inter-
acts physically and functionally with
a ubiquitin ligase: implications for
ﬁlovirus budding. Proc. Natl. Acad.
Sci. U.S.A. 97, 13871–13876.
Harty, R. N., Paragas, J., Sudol, M.,
and Palese, P. (1999). A proline-
rich motif within the matrix pro-
tein of vesicular stomatitis virus
and rabies virus interacts with WW
domains of cellular proteins: impli-
cationsforviralbudding.J.Virol.73,
2921–2929.
Frontiers in Microbiology | Cellular and Infection Microbiology July 2011 | Volume 2 | Article 161 | 18Gustin et al. Viral takeover of the host ubiquitin system
Herr,R.A.,Harris,J.,Fang,S.,Wang,X.,
and Hansen, T. H. (2009). Role of
the RING-CH domain of viral ligase
mK3inubiquitinationof non-lysine
and lysine MHC I residues. Trafﬁc
10, 1301–1317.
Hershko, A., and Ciechanover, A.
(1998). The ubiquitin system.Annu.
Rev. Biochem. 67, 425–479.
Hicke,L.,Schubert,H. L.,and Hill,C. P.
(2005).Ubiquitin-bindingdomains.
Nat. Rev. Mol. Cell Biol. 6, 610–621.
Hilton, L., Moganeradj, K., Zhang, G.,
Chen,Y.H.,Randall,R.E.,Mccauley,
J.W.,andGoodbourn,S.(2006).The
NPro product of bovine viral diar-
rhea virus inhibits DNA binding by
interferon regulatory factor 3 and
targets it for proteasomal degrada-
tion. J. Virol. 80, 11723–11732.
Hochstrasser, M. (2009). Origin and
function of ubiquitin-like proteins.
Nature 458, 422–429.
Hoppe, T. (2005). Multiubiquitylation
by E4 enzymes:“one size”doesn’t ﬁt
all.TrendsBiochem.Sci.30,183–187.
Howie, H. L., Katzenellenbogen, R. A.,
and Galloway, D. A. (2009). Papil-
lomavirus E6 proteins.Virology 384,
324–334.
Huang, J., Huang, Q., Zhou, X., Shen,
M. M., Yen, A., Yu, S. X., Dong,
G., Qu, K., Huang, P., Anderson, E.
M.,Daniel-Issakani,S.,Buller,R.M.,
Payan, D. G., and Lu, H. H. (2004).
The poxvirus p28 virulence factor is
an E3 ubiquitin ligase. J. Biol. Chem.
279, 54110–54116.
Huh,K.,Zhou,X.,Hayakawa,H.,Cho,J.
Y.,Libermann,T.A.,Jin,J.,Harper,J.
W., and Munger, K. (2007). Human
papillomavirus type 16 E7 onco-
protein associates with the cullin
2 ubiquitin ligase complex, which
contributes to degradation of the
retinoblastoma tumor suppressor. J.
Virol. 81, 9737–9747.
Hwang, J., and Kalejta, R. F. (2007).
Proteasome-dependent, ubiquitin-
independent degradation of Daxx
by the viral pp71 protein in human
cytomegalovirus-infected cells.
Virology 367, 334–338.
Hwang, J., and Kalejta, R. F. (2009).
Human cytomegalovirus protein
pp71inducesDaxxSUMOylation.J.
Virol. 83, 6591–6598.
Ikeda, M., Ikeda, A., and Longnecker,
R. (2001). PY motifs of Epstein-
Barr virus LMP2A regulate pro-
teinstabilityandphosphorylationof
LMP2A-associated proteins. J. Virol.
75, 5711–5718.
Ikeda, M., and Longnecker, R. (2009).
Thec-Cblproto-oncoproteindown-
regulates EBV LMP2A signaling.
Virology 385, 183–191.
Indoh, T., Yokota, S., Okabayashi, T.,
Yokosawa, N., and Fujii, N. (2007).
SuppressionofNF-kappaBandAP-1
activation in monocytic cells persis-
tently infected with measles virus.
Virology 361, 294–303.
Irie, T., Licata, J. M., Mcgettigan, J.
P., Schnell, M. J., and Harty, R. N.
(2004).BuddingofPPxY-containing
rhabdoviruses is not dependent on
host proteins TGS101 andVPS4A. J.
Virol. 78, 2657–2665.
Isaacson, M. K., and Ploegh, H. L.
(2009). Ubiquitination, ubiquitin-
like modiﬁers,and deubiquitination
in viral infection. Cell Host Microbe
5, 559–570.
Ishido,S.,Choi,J.K.,Lee,B.S.,Wang,C.,
Demaria, M., Johnson, R. P., Cohen,
G. B., and Jung, J. U. (2000a). Inhi-
bitionof naturalkillercell-mediated
cytotoxicity by Kaposi’s sarcoma-
associated herpesvirus K5 protein.
Immunity 13, 365–374.
Ishido,S.,Wang,C.,Lee,B.S.,Cohen,G.
B., and Jung, J. U. (2000b). Down-
regulation of major histocompat-
ibility complex class I molecules
by Kaposi’s sarcoma-associated her-
pesvirusK3andK5proteins.J.Virol.
74, 5300–5309.
Isobe, T., Hattori, T., Kitagawa, K.,
Uchida, C., Kotake, Y., Kosugi, I.,
Oda, T., and Kitagawa, M. (2009).
AdenovirusE1AinhibitsSCF(Fbw7)
ubiquitin ligase. J. Biol. Chem. 284,
27766–27779.
Ivanov, A. V., Peng, H., Yurchenko, V.,
Yap, K. L., Negorev, D. G., Schultz,
D. C., Psulkowski, E., Fredericks,
W. J., White, D. E., Maul, G. G.,
Sadofsky, M. J., Zhou, M. M., and
Rauscher, F. J. III. (2007). PHD
domain-mediated E3 ligase activ-
ity directs intramolecular sumoyla-
tion of an adjacent bromodomain
requiredforgenesilencing.Mol.Cell
28, 823–837.
Iwabu, Y., Fujita, H., Kinomoto, M.,
Kaneko, K., Ishizaka, Y., Tanaka,
Y., Sata, T., and Tokunaga, K.
(2009). HIV-1 accessory pro-
tein Vpu internalizes cell-surface
BST-2/tetherin through trans-
membrane interactions leading
to lysosomes. J. Biol. Chem. 284,
35060–35072.
Iwatani, Y., Chan, D. S., Liu, L., Yoshii,
H.,Shibata,J.,Yamamoto,N.,Levin,
J. G., Gronenborn, A. M., and Sug-
iura,W.(2009).HIV-1Vif-mediated
ubiquitination/degradation of
APOBEC3G involves four critical
lysine residues in its C-terminal
domain. Proc. Natl. Acad. Sci. U.S.A.
106, 19539–19544.
Jarosinski, K., Kattenhorn, L., Kaufer,
B., Ploegh, H., and Osterrieder, N.
(2007). A herpesvirus ubiquitin-
speciﬁc protease is critical for efﬁ-
cient T cell lymphoma formation.
Proc. Natl. Acad. Sci. U.S.A. 104,
20025–20030.
Jha, S., Vande Pol, S., Banerjee, N. S.,
Dutta,A. B., Chow, L. T., and Dutta,
A. (2010). Destabilization of TIP60
by human papillomavirus E6 results
in attenuation of TIP60-dependent
transcriptionalregulationandapop-
toticpathway.Mol.Cell 38,700–711.
Jia, B., Serra-Moreno, R., Neidermyer,
W.,Rahmberg,A.,Mackey,J.,Fofana,
I. B., Johnson,W. E.,Westmoreland,
S., and Evans, D. T. (2009). Species-
speciﬁc activity of SIV Nef and
HIV-1 Vpu in overcoming restric-
tion by tetherin/BST2. PLoS Pathog.
5, e1000429. doi: 10.1371/jour-
nal.ppat.1000429
Johnston, J. B., Wang, G., Barrett,
J. W., Nazarian, S. H., Colwill,
K., Moran, M., and Mcfadden, G.
(2005). Myxoma virus M-T5 pro-
tects infected cells from the stress of
cell cycle arrest through its interac-
tion with host cell cullin-1. J. Virol.
79, 10750–10763.
Jouvenet, N., Neil, S. J., Zhadina,
M., Zang, T., Kratovac, Z., Lee,
Y., Mcnatt, M., Hatziioannou, T.,
and Bieniasz, P. D. (2009). Broad-
spectrum inhibition of retroviral
and ﬁloviral particle release by teth-
erin. J. Virol. 83, 1837–1844.
Jowett,J.B.,Planelles,V.,Poon,B.,Shah,
N. P., Chen, M. L., and Chen, I.
S. (1995). The human immunode-
ﬁciency virus type 1 vpr gene arrests
infected T cells in the G2 + M
phase of the cell cycle. J. Virol. 69,
6304–6313.
Kaletsky, R. L., Francica, J. R., Agrawal-
Gamse, C., and Bates, P. (2009).
Tetherin-mediated restriction of
ﬁlovirus budding is antagonized by
the Ebola glycoprotein. Proc. Natl.
Acad. Sci. U.S.A. 106, 2886–2891.
Kamio, M., Yoshida, T., Ogata, H.,
Douchi, T., Nagata, Y., Inoue, M.,
Hasegawa, M., Yonemitsu, Y., and
Yoshimura, A. (2004). SOCS1 [cor-
rected] inhibits HPV-E7-mediated
transformation by inducing degra-
dation of E7 protein. Oncogene 23,
3107–3115.
Kanneganti, T. D. (2010). Central roles
ofNLRsandinﬂammasomesinviral
infection. Nat. Rev. Immunol. 10,
688–698.
Karuppannan, A. K., Liu, S., Jia, Q.,
Selvaraj, M., and Kwang, J. (2010).
Porcine circovirus type 2 ORF3 pro-
tein competes with p53 in binding
to Pirh2 and mediates the deregu-
lation of p53 homeostasis. Virology
398, 1–11.
Kattenhorn,L.M.,Korbel,G.A.,Kessler,
B. M.,Spooner,E.,and Ploegh,H. L.
(2005). A deubiquitinating enzyme
encodedbyHSV-1belongstoafam-
ily of cysteine proteases that is con-
served across the family Herpesviri-
dae. Mol. Cell 19, 547–557.
Kew, M. C. (2011). Hepatitis B virus
x protein in the pathogenesis of
hepatitis B virus-induced hepato-
cellular carcinoma. J. Gastroenterol.
Hepatol. 26(Suppl. 1), 144–152.
Kfoury, Y., Setterblad, N., El-Sabban,
M., Zamborlini, A., Dassouki, Z., El
Hajj, H., Hermine, O., Pique, C., De
the, H., Saib, A., and Bazarbachi,
A. (2010). Tax ubiquitylation and
SUMOylation control the dynamic
shuttlingofTaxandNEMObetween
Ubc9nuclearbodiesandthecentro-
some. Blood 117, 190–199.
Kian Chua, P., Lin, M. H., and Shih, C.
(2006). Potent inhibition of human
Hepatitis B virus replication by a
host factorVps4. Virology 354, 1–6.
Knight, J. S., Sharma, N., and Robert-
son,E.S.(2005a).Epstein-Barrvirus
latent antigen 3C can mediate the
degradation of the retinoblastoma
protein through an SCF cellular
ubiquitinligase.Proc.Natl.Acad.Sci.
U.S.A. 102, 18562–18566.
Knight,J.S.,Sharma,N.,andRobertson,
E.S.(2005b).SCFSkp2complextar-
geted by Epstein-Barr virus essential
nuclear antigen. Mol. Cell. Biol. 25,
1749–1763.
Koegl, M., Hoppe, T., Schlenker, S.,
Ulrich, H. D., Mayer, T. U., and
Jentsch, S. (1999). A novel ubiqui-
tination factor, E4, is involved in
multiubiquitin chain assembly. Cell
96, 635–644.
Komander, D. (2009). The emerg-
ing complexity of protein ubiqui-
tination. Biochem. Soc. Trans. 37,
937–953.
Kornitzer, D., Sharf, R., and Klein-
berger,T.(2001).AdenovirusE4orf4
protein induces PP2A-dependent
growth arrest in Saccharomyces
cerevisiae and interacts with
the anaphase-promoting com-
plex/cyclosome. J. Cell Biol. 154,
331–344.
Koziorowska, J., Wlodarski, K., and
Mazurowa, N. (1971). Transforma-
tion of mouse emnbryo cells by vac-
cinia virus. J. Natl. Cancer Inst. 46,
225–241.
Lagunas-Martinez, A., Madrid-Marina,
V., and Gariglio, P. (2010). Modu-
lation of apoptosis by early human
papillomavirus proteins in cervical
cancer. Biochim. Biophys. Acta 1805,
6–16.
Lambert, C., Doring, T., and Prange,
R. (2007). Hepatitis B virus matura-
tion is sensitive to functional inhibi-
tionofESCRT-III,Vps4,andgamma
2-adaptin. J. Virol. 81, 9050–9060.
Le Tortorec, A., and Neil, S. J. (2009).
Antagonism to and intracellular
sequestration of human tetherin by
the human immunodeﬁciency virus
type2envelopeglycoprotein.J.Virol.
83, 11966–11978.
www.frontiersin.org July 2011 | Volume 2 | Article 161 | 19Gustin et al. Viral takeover of the host ubiquitin system
Lee, T. H., Elledge, S. J., and Butel, J.
S. (1995). Hepatitis B virus X pro-
tein interacts with a probable cellu-
lar DNA repair protein. J. Virol. 69,
1107–1114.
Leechanachai, P., Banks, L., Moreau,
F., and Matlashewski, G. (1992).
The E5 gene from human papil-
l o m a v i r u st y p e1 6i sa no n c o -
gene which enhances growth factor-
mediated signal transduction to the
nucleus. Oncogene 7, 19–25.
Li,Q.,Means,R.,Lang,S.,andJung,J.U.
(2007). Downregulation of gamma
interferon receptor 1 by Kaposi’s
sarcoma-associated herpesvirus K3
and K5. J. Virol. 81, 2117–2127.
Li, W., Bengtson, M. H., Ulbrich,
A., Matsuda, A., Reddy, V. A.,
Orth, A., Chanda, S. K., Batalov,
S., and Joazeiro, C. A. (2008).
Genome-wide and functional anno-
tation of human E3 ubiquitin lig-
ases identiﬁes MULAN, a mito-
chondrial E3 that regulates the
organelle’s dynamics and signal-
ing. PLoS ONE 3, e1487. doi:
10.1371/journal.pone.0001487
Lichtig, H., Gilboa, D. A., Jackman, A.,
Gonen, P., Levav-Cohen, Y., Haupt,
Y., and Sherman, L. (2010). HPV16
E6 augments Wnt signaling in an
E6AP-dependent manner. Virology
396, 47–58.
Lilley,B. N.,and Ploegh,H. L. (2004).A
membrane protein required for dis-
location of misfolded proteins from
the ER. Nature 429, 834–840.
Lilley, B. N., and Ploegh, H. L.
(2005). Multiprotein complexes that
link dislocation,ubiquitination,and
extraction of misfolded proteins
from the endoplasmic reticulum
membrane. Proc. Natl. Acad. Sci.
U.S.A. 102, 14296–14301.
Lin, C. H., Chang, H. S., and Yu, W. C.
(2008). USP11 stabilizes HPV-16E7
and further modulates the E7 bio-
logical activity. J. Biol. Chem. 283,
15681–15688.
Liu, J., Zhu, Y., Chen, I., Lau, J., He, F.,
Lau, A., Wang, Z., Karuppannan, A.
K., and Kwang, J. (2007). The ORF3
protein of porcine circovirus type
2 interacts with porcine ubiquitin
E3 ligase Pirh2 and facilitates p53
expression in viral infection. J.Virol.
81, 9560–9567.
Liu, M., Schmidt, E. E., and Hal-
ford, W. P. (2010). ICP0 disman-
tles microtubule networks in Her-
pessimplexvirus-infectedcells.PLoS
ONE 5, e10975. doi: 10.1371/jour-
nal.pone.0010975
Loureiro, J., Lilley, B. N., Spooner,
E., Noriega, V., Tortorella, D., and
Ploegh, H. L. (2006). Signal peptide
peptidase is required for dislocation
from the endoplasmic reticulum.
Nature 441, 894–897.
Lupfer, C., and Pastey, M. K. (2010).
Decreasedreplicationof humanres-
piratory syncytial virus treated with
the proteasome inhibitor MG-132.
Virus Res. 149, 36–41.
Lupfer, C., Patton, K. M., and Pastey,
M. K. (2010). Treatment of human
respiratory syncytial virus infected
Balb/C mice with the proteasome
inhibitor bortezomib (Velcade, PS-
341) results in increased inﬂamma-
tion and mortality. Toxicology 268,
25–30.
Lybarger, L., Wang, X., Harris, M. R.,
Virgin, H. W. T., and Hansen, T.
H. (2003). Virus subversion of the
MHC class I peptide-loading com-
plex. Immunity 18, 121–130.
Ma, X. Z., Bartczak, A., Zhang, J.,
Khattar, R., Chen, L., Liu, M. F.,
Edwards,A.,Levy,G.,andMcgilvray,
I. D. (2010). Proteasome inhibi-
tion in vivo promotes survival in a
lethal murine model of severe acute
respiratory syndrome. J. Virol. 84,
12419–12428.
Mammas, I. N., Sourvinos, G., Gian-
noudis, A., and Spandidos, D. A.
(2008). Human papilloma virus
(HPV) and host cellular inter-
actions. Pathol. Oncol. Res. 14,
345–354.
Manes, T. D., Hoer, S., Muller, W.
A., Lehner, P. J., and Pober, J. S.
(2010). Kaposi’s sarcoma-associated
herpesvirus K3 and K5 proteins
blockdistinctstepsintransendothe-
lial migration of effector memory
CD4+ T cells by targeting differ-
entendothelialproteins.J.Immunol.
184, 5186–5192.
Mangeat,B.,Gers-Huber,G.,Lehmann,
M., Zufferey, M., Luban, J.,
and Piguet, V. (2009). HIV-1
Vpu neutralizes the antivi-
ral factor Tetherin/BST-2 by
binding it and directing its beta-
TrCP2-dependent degradation.
PLoS Pathog. 5, e1000574. doi:
10.1371/journal.ppat.1000574
Mansouri, M., Bartee, E., Gouveia, K.,
Hovey Nerenberg, B. T., Barrett, J.,
Thomas, L., Thomas, G., Mcfad-
den, G., and Fruh, K. (2003). The
PHD/LAP-domain protein M153R
of myxomavirus is a ubiquitin lig-
ase that induces the rapid internal-
izationandlysosomaldestructionof
CD4. J. Virol. 77, 1427–1440.
Mansouri, M., Douglas, J., Rose, P. P.,
Gouveia, K., Thomas, G., Means,
R. E., Moses, A. V., and Fruh,
K. (2006). Kaposi sarcoma her-
pesvirus K5 removes CD31/PECAM
from endothelial cells. Blood 108,
1932–1940.
Mansouri, M., Viswanathan, K., Dou-
glas, J. L., Hines, J., Gustin,
J., Moses, A. V., and Fruh, K.
(2009). Molecular mechanism of
BST2/tetherin downregulation by
K5/MIR2 of Kaposi’s sarcoma-
associated herpesvirus. J. Virol. 83,
9672–9681.
Marin, I. (2010). Ancient origin of
animal U-box ubiquitin ligases.
BMC Evol. Biol. 10, 331. doi:
10.1186/1471-2148-10-331
Marin, M., Rose, K. M., Kozak, S. L.,
and Kabat, D. (2003). HIV-1 Vif
protein binds the editing enzyme
APOBEC3G and induces its degra-
dation. Nat. Med. 9, 1398–1403.
Maringer, K., and Elliott, G. (2010).
Recruitment of Herpes simplex virus
type1immediate-earlyproteinICP0
to the virus particle. J. Virol. 84,
4682–4696.
Martin-Lluesma, S., Schaeffer, C.,
Robert, E. I., Van Breugel, P. C.,
Leupin, O., Hantz, O., and Strubin,
M. (2008). Hepatitis B virus X
protein affects S phase progression
leading to chromosome segregation
defects by binding to damaged DNA
binding protein 1. Hepatology 48,
1467–1476.
Martin-Serrano, J. (2007). The role of
ubiquitin in retroviral egress. Trafﬁc
8, 1297–1303.
Maufort, J. P., Shai, A., Pitot, H. C.,
and Lambert, P. F. (2010). A role for
HPV16 E5 in cervical carcinogene-
sis. Cancer Res. 70, 2924–2931.
Mayer, R. J. (2000). The meteoric rise
ofregulatedintracellularproteolysis.
Nat. Rev. Mol. Cell Biol. 1, 145–148.
Mazzon, M., Jones, M., Davidson,
A., Chain, B., and Jacobs, M.
(2009). Dengue virus NS5 inhibits
interferon-alpha signaling by block-
ing signal transducer and acti-
vator of transcription 2 phos-
phorylation. J. Infect. Dis. 200,
1261–1270.
McCall, C. M., Miliani De Marval, P.
L., Chastain, P. D. II, Jackson, S.
C., He, Y. J., Kotake, Y., Cook, J.
G., and Xiong, Y. (2008). Human
immunodeﬁciencyvirustype1Vpr-
binding protein VprBP, a WD40
protein associated with the DDB1-
CUL4 E3 ubiquitin ligase, is essen-
tial for DNA replication and embry-
onicdevelopment.Mol.Cell.Biol.28,
5621–5633.
Melnick, A., and Licht, J. D. (1999).
Deconstructing a disease: RARal-
pha, its fusion partners, and their
roles in the pathogenesis of acute
promyelocytic leukemia. Blood 93,
3167–3215.
Mettenleiter, T. C., Klupp, B. G., and
Granzow, H. (2009). Herpesvirus
assembly: an update. Virus Res. 143,
222–234.
Mitchell, R. S., Katsura, C., Skasko, M.
A., Fitzpatrick, K., Lau, D., Ruiz, A.,
Stephens, E. B., Margottin-Goguet,
F., Benarous, R., and Guatelli, J.
C. (2009). Vpu antagonizes BST-
2-mediated restriction of HIV-1
release via beta-TrCP and endo-
lysosomal trafﬁcking. PLoS Pathog.
5, e1000450. doi: 10.1371/jour-
nal.ppat.1000450
Miura, S., Kawana, K., Schust, D. J.,
Fujii, T., Yokoyama, T., Iwasawa, Y.,
Nagamatsu, T., Adachi, K., Tomio,
A., Tomio, K., Kojima, S., Yasugi,
T., Kozuma, S., and Taketani, Y.
(2010). CD1d, a sentinel mole-
cule bridging innate and adaptive
immunity, is downregulated by the
human papillomavirus (HPV) E5
protein: a possible mechanism for
immuneevasionbyHPV.J.Virol.84,
11614–11623.
Mo, M., Fleming, S. B., and Mercer,
A. A. (2009). Cell cycle deregula-
tion by a poxvirus partial mimic of
anaphase-promoting complex sub-
unit 11. Proc. Natl. Acad. Sci. U.S.A.
106, 19527–19532.
Mo, M., Fleming, S. B., and Mercer, A.
A. (2010). Orf virus cell cycle reg-
ulator, PACR, competes with sub-
unit 11 of the anaphase promot-
ing complex for incorporation into
the complex. J. Gen. Virol. 91,
3010–3015.
Molina-Jimenez, F., Benedicto, I.,
Murata, M., Martin-Vilchez, S.,
Seki, T., Antonio Pintor-Toro,
J., Tortolero, M., Moreno-Otero,
R., Okazaki, K., Koike, K., Bar-
bero, J. L., Matsuzaki, K., Majano,
P. L., and Lopez-Cabrera, M.
(2010). Expression of pituitary
tumor-transforming gene 1
(PTTG1)/securininhepatitisBvirus
(HBV)-associated liver diseases:
evidence for an HBV X protein-
mediated inhibition of PTTG1
ubiquitination and degradation.
Hepatology 51, 777–787.
Moody,C.A.,andLaimins,L.A.(2010).
Human papillomavirus oncopro-
teins: pathways to transformation.
Nat. Rev. Cancer 10, 550–560.
Mueller, B., Klemm, E. J., Spooner,
E., Claessen, J. H., and Ploegh, H.
L. (2008). SEL1L nucleates a pro-
tein complex required for dislo-
cation of misfolded glycoproteins.
Proc. Natl. Acad. Sci. U.S.A. 105,
12325–12330.
Mueller, B., Lilley, B. N., and Ploegh, H.
L. (2006). SEL1L, the homologue of
yeast Hrd3p, is involved in protein
dislocation from the mammalian
ER. J. Cell Biol. 175, 261–270.
Frontiers in Microbiology | Cellular and Infection Microbiology July 2011 | Volume 2 | Article 161 | 20Gustin et al. Viral takeover of the host ubiquitin system
Mui, M. Z., Roopchand, D. E.,
Gentry, M. S., Hallberg, R. L.,
Vogel, J., and Branton, P. E.
(2010). Adenovirus protein E4orf4
induces premature APCCdc20 acti-
vation in Saccharomyces cerevisiae
by a protein phosphatase 2A-
dependent mechanism. J. Virol. 84,
4798–4809.
Nasr, R., Chiari, E., El-Sabban, M.,
Mahieux, R., Kfoury, Y., Abdul-
hay, M., Yazbeck, V., Hermine,
O., De the, H., Pique, C., and
Bazarbachi,A. (2006). Tax ubiquity-
lation and sumoylation control crit-
ical cytoplasmic and nuclear steps
of NF-kappaBactivation.Blood 107,
4021–4029.
Nayak, R., Farris, K. D., and Pintel, D. J.
(2008).E4Orf6-E1B-55k-dependent
degradation of de novo-generated
adeno-associated virus type 5 Rep52
and capsid proteins employs a cullin
5-containing E3 ligase complex. J.
Virol. 82, 3803–3808.
Neil,S.,and Bieniasz,P. (2009). Human
immunodeﬁciency virus, restriction
factors, and interferon. J. Interferon
Cytokine Res. 29, 569–580.
Neil, S. J., Zang, T., and Bieniasz, P. D.
(2008). Tetherin inhibits retrovirus
release and is antagonized by HIV-1
Vpu. Nature 451, 425–430.
Nerenberg, B. T., Taylor, J., Bartee, E.,
Gouveia, K., Barry, M., and Fruh,
K. (2005). The poxviral RING pro-
tein p28 is a ubiquitin ligase that
targets ubiquitin to viral replication
factories. J. Virol. 79, 597–601.
Nguyen, H., Sankaran, S., and Dan-
dekar, S. (2006). Hepatitis C virus
core protein induces expression of
genes regulating immune evasion
and anti-apoptosis in hepatocytes.
Virology 354, 58–68.
Ning, S., Campos, A. D., Darnay, B. G.,
Bentz,G.L.,andPagano,J.S.(2008).
TRAF6 and the three C-terminal
lysine sites on IRF7 are required
foritsubiquitination-mediatedacti-
vation by the tumor necrosis fac-
tor receptor family member latent
membrane protein 1. Mol. Cell. Biol.
28, 6536–6546.
Ning, S., and Pagano, J. S. (2010). The
A20 deubiquitinase activity nega-
tively regulates LMP1 activation of
IRF7. J. Virol. 84, 6130–6138.
Oh, J. M., Kim, S. H., Cho, E.
A., Song, Y. S., Kim, W. H.,
and Juhnn, Y. S. (2010). Human
papillomavirus type 16 E5 pro-
tein inhibits hydrogen-peroxide-
induced apoptosis by stimulat-
ing ubiquitin-proteasome-mediated
degradation of Bax in human cer-
vical cancer cells. Carcinogenesis 31,
402–410.
Oh, K. J., Kalinina, A., Wang, J.,
Nakayama, K., Nakayama, K. I.,
and Bagchi, S. (2004). The papillo-
mavirus E7 oncoprotein is ubiquiti-
nated by UbcH7 and Cullin 1- and
Skp2-containing E3 ligase. J. Virol.
78, 5338–5346.
Ohi, M. D.,Vander Kooi, C. W., Rosen-
berg, J. A., Chazin,W. J., and Gould,
K. L. (2003). Structural insights
into the U-box, a domain associ-
atedwithmulti-ubiquitination.Nat.
Struct. Biol. 10, 250–255.
Okumura, A., Alce, T., Lubyova, B.,
Ezelle, H., Strebel, K., and Pitha,
P. M. (2008). HIV-1 accessory pro-
teins VPR and Vif modulate antivi-
ral response by targeting IRF-3 for
degradation. Virology 373, 85–97.
Onose, A., Hashimoto, S., Hayashi, S.,
Maruoka, S., Kumasawa, F., Mizu-
mura, K., Jibiki, I., Matsumoto, K.,
Gon, Y., Kobayashi, T., Takahashi,
N., Shibata,Y., Abiko,Y., Shibata, T.,
Shimizu, K., and Horie, T. (2006).
An inhibitory effect of A20 on NF-
kappaB activation in airway epithe-
lium upon inﬂuenza virus infection.
Eur. J. Pharmacol. 541, 198–204.
Ott, D. E., Coren, L. V., Copeland, T.
D., Kane, B. P., Johnson, D. G., Sow-
der, R. C. II, Yoshinaka, Y., Oros-
zlan, S., Arthur, L. O., and Hender-
son, L. E. (1998). Ubiquitin is cova-
lently attached to the p6Gag pro-
teins of human immunodeﬁciency
virus type 1 and simian immunode-
ﬁciencyvirusandtothep12Gagpro-
tein of Moloney murine leukemia
virus. J. Virol. 72, 2962–2968.
Paladino,P.,andMossman,K.L.(2009).
Mechanisms employed by Herpes
simplex virus 1 to inhibit the inter-
feronresponse.J.InterferonCytokine
Res. 29, 599–607.
Parisien, J. P., Lau, J. F., Rodriguez, J.
J., Ulane, C. M., and Horvath, C.
M. (2002). Selective STAT protein
degradation induced by paramyx-
oviruses requires both STAT1 and
STAT2 but is independent of
alpha/beta interferon signal trans-
duction. J. Virol. 76, 4190–4198.
Patient, R., Hourioux, C., and
Roingeard, P. (2009). Morpho-
genesis of hepatitis B virus and its
subviral envelope particles. Cell.
Microbiol. 11, 1561–1570.
Patnaik, A., Chau, V., and Wills, J. W.
(2000).Ubiquitinispartoftheretro-
virusbuddingmachinery.Proc.Natl.
Acad. Sci. U.S.A. 97, 13069–13074.
Pawliczek, T., and Crump, C. M.
(2009). Herpes simplex virus type
1 production requires a func-
tional ESCRT-III complex but
is independent of TSG101 and
ALIX expression. J. Virol. 83,
11254–11264.
Perez, M., Craven, R. C., and De La
Torre, J. C. (2003). The small RING
ﬁnger protein Z drives arenavirus
budding: implications for antivi-
ral strategies. Proc. Natl. Acad. Sci.
U.S.A. 100, 12978–12983.
Pickart, C. M. (2001). Mechanisms
underlying ubiquitination. Annu.
Rev. Biochem. 70, 503–533.
Portis, T., Ikeda, M., and Long-
necker,R.(2004).Epstein-Barrvirus
LMP2A: regulating cellular ubiqui-
tination processes for maintenance
of viral latency?Trends Immunol. 25,
422–426.
Puckett, C., and Moss, B. (1983). Selec-
tive transcription of vaccinia virus
genes in template dependent solu-
ble extracts of infected cells. Cell 35,
441–448.
Putterman,D.,Pepinsky,R.B.,andVogt,
V. M. (1990). Ubiquitin in avian
leukosisvirusparticles.Virology 176,
633–637.
Querido, E., Blanchette, P., Yan, Q.,
Kamura, T., Morrison, M., Boivin,
D., Kaelin, W. G., Conaway, R. C.,
Conaway, J. W., and Branton, P. E.
(2001). Degradation of p53 by ade-
novirus E4orf6 and E1B55K pro-
teins occurs via a novel mechanism
involving a Cullin-containing com-
plex. Genes Dev. 15, 3104–3117.
Raaben, M., Grinwis, G. C., Rot-
tier, P. J., and De Haan, C. A.
(2010a). The proteasome inhibitor
Velcade enhances rather than
reduces disease in mouse hepatitis
coronavirus-infected mice. J. Virol.
84, 7880–7885.
Raaben, M., Posthuma, C. C., Verheije,
M. H., Te Lintelo, E. G., Kikkert, M.,
Drijfhout,J.W.,Snijder,E.J.,Rottier,
P.J.,andDeHaan,C.A.(2010b).The
ubiquitin-proteasome system plays
an important role during various
stages of the coronavirus infection
cycle. J. Virol. 84, 7869–7879.
Rampias, T., Boutati, E., Pectasides, E.,
Sasaki, C., Kountourakis, P., Wein-
berger,P.,andPsyrri,A.(2010).Acti-
vation of Wnt signaling pathway
by human papillomavirus E6 and
E7 oncogenes in HPV16-positive
oropharyngealsquamouscarcinoma
cells. Mol. Cancer Res. 8, 433–443.
Randow, F., and Lehner, P. J. (2009).
Viral avoidance and exploitation of
the ubiquitin system. Nat. Cell Biol.
11, 527–534.
Ratia, K., Pegan, S., Takayama, J., Slee-
man, K., Coughlin, M., Baliji, S.,
Chaudhuri, R., Fu, W., Prabhakar,
B. S., Johnson, M. E., Baker, S.
C., Ghosh, A. K., and Mesecar, A.
D. (2008). A noncovalent class of
papain-like protease/deubiquitinase
inhibitors blocks SARS virus repli-
cation. Proc. Natl. Acad. Sci. U.S.A.
105, 16119–16124.
Reinstein, E., Scheffner, M., Oren,
M., Ciechanover, A., and Schwartz,
A. (2000). Degradation of the E7
human papillomavirus oncoprotein
bytheubiquitin-proteasomesystem:
targeting via ubiquitination of the
N-terminal residue. Oncogene 19,
5944–5950.
Rhodes, D. A., Boyle, L. H., Boname, J.
M., Lehner, P. J., and Trowsdale, J.
(2010).Ubiquitinationof lysine-331
by Kaposi’s sarcoma-associated her-
pesvirus protein K5 targets HFE for
lysosomal degradation. Proc. Natl.
Acad. Sci. U.S.A. 107, 16240–16245.
Robert, A., Miron, M. J., Champagne,
C., Gingras, M. C., Branton, P. E.,
and Lavoie, J. N. (2002). Distinct
cell death pathways triggered by the
adenovirus early region 4 ORF 4
protein. J. Cell Biol. 158, 519–528.
Rodrigues, L., Filipe, J., Seldon, M. P.,
Fonseca, L., Anrather, J., Soares, M.
P., and Simas, J. P. (2009). Termina-
tion of NF-kappaB activity through
a gammaherpesvirus protein that
assembles an EC5S ubiquitin-ligase.
EMBO J. 28, 1283–1295.
Rogel, M. E., Wu, L. I., and Emerman,
M.(1995).Thehumanimmunodeﬁ-
ciencyvirustype1vprgeneprevents
cell proliferation during chronic
infection. J. Virol. 69, 882–888.
Ros, C., and Kempf, C. (2004). The
ubiquitin-proteasome machinery is
essential for nuclear translocation
of incoming minute virus of mice.
Virology 324, 350–360.
Rost,M.,Mann,S.,Lambert,C.,Doring,
T.,Thome,N.,andPrange,R.(2006).
Gamma-adaptin, a novel ubiquitin-
interacting adaptor, and Nedd4
ubiquitin ligase control hepatitis B
virus maturation. J. Biol. Chem. 281,
29297–29308.
Rotin,D.,andKumar,S.(2009).Physio-
logicalfunctionsoftheHECTfamily
of ubiquitin ligases. Nat. Rev. Mol.
Cell Biol. 10, 398–409.
Saffert, R. T., and Kalejta, R. F. (2006).
Inactivating a cellular intrinsic
immune defense mediated by Daxx
is the mechanism through which
the human cytomegalovirus pp71
protein stimulates viral immediate-
early gene expression. J. Virol. 80,
3863–3871.
Saha,A.,Halder,S.,Upadhyay,S. K.,Lu,
J.,Kumar,P.,Murakami,M.,Cai,Q.,
andRobertson,E.S.(2011).Epstein-
Barr virus nuclear antigen 3C facil-
itates G1-S transition by stabilizing
andenhancingthefunctionof cyclin
D1. PLoS Pathog. 7, e1001275. doi:
10.1371/journal.ppat.1001275
Saha, A., Murakami, M., Kumar, P.,
Bajaj, B., Sims, K., and Robert-
son, E. S. (2009). Epstein-Barr
virus nuclear antigen 3C aug-
ments Mdm2-mediated p53 ubiq-
uitination and degradation by deu-
biquitinating Mdm2. J. Virol. 83,
4652–4669.
www.frontiersin.org July 2011 | Volume 2 | Article 161 | 21Gustin et al. Viral takeover of the host ubiquitin system
Sanchez, D. J., Gumperz, J. E., and
Ganem, D. (2005). Regulation of
CD1d expression and function by a
herpesvirus infection. J. Clin. Invest.
115, 1369–1378.
Sarkari, F., Sanchez-Alcaraz, T., Wang,
S., Holowaty, M. N., Sheng, Y.,
and Frappier, L. (2009). EBNA1-
mediated recruitment of a histone
H2B deubiquitylating complex to
the Epstein-Barr virus latent origin
of DNA replication. PLoS Pathog.
5, e1000624. doi: 10.1371/jour-
nal.ppat.1000624
Satheshkumar, P. S., Anton, L. C., Sanz,
P., and Moss, B. (2009). Inhibition
of the ubiquitin-proteasome system
prevents vaccinia virus DNA repli-
cation and expression of interme-
diate and late genes. J. Virol. 83,
2469–2479.
Scaglioni, P. P., Yung, T. M., Choi,
S., Baldini, C., Konstantinidou,
G., and Pandolﬁ, P. P. (2008).
CK2 mediates phosphorylation and
ubiquitin-mediated degradation of
the PML tumor suppressor. Mol.
Cell. Biochem. 316, 149–154.
Scheffner, M., Werness, B. A.,
Huibregtse, J. M., Levine, A. J.,
and Howley, P. M. (1990). The E6
oncoprotein encoded by human
papillomavirus types 16 and 18
promotes the degradation of p53.
Cell 63, 1129–1136.
Schmitt, A. P., Leser, G. P., Morita, E.,
Sundquist, W. I., and Lamb, R. A.
(2005).Evidenceforanewvirallate-
domain core sequence, FPIV, neces-
saryforbuddingofaparamyxovirus.
J. Virol. 79, 2988–2997.
Schmitt, A. P., Leser, G. P., Waning, D.
L.,and Lamb,R.A. (2002). Require-
mentsforbuddingofparamyxovirus
simian virus 5 virus-like particles. J.
Virol. 76, 3952–3964.
Schreiner, S., Wimmer, P., Sirma,
H., Everett, R. D., Blanchette, P.,
Groitl, P., and Dobner, T. (2010).
Proteasome-dependent degradation
ofDaxxbytheviralE1B-55Kprotein
in human adenovirus-infected cells.
J. Virol. 84, 7029–7038.
Schubert, U., Bour, S., Ferrer-Montiel,
A. V., Montal, M., Maldarell, F.,
and Strebel, K. (1996). The two
biological activities of human
immunodeﬁciency virus type 1
Vpu protein involve two separable
structural domains. J. Virol. 70,
809–819.
Schubert,U.,Ott,D. E.,Chertova,E. N.,
Welker, R., Tessmer, U., Princiotta,
M. F., Bennink, J. R., Krausslich, H.
G., and Yewdell, J. W. (2000). Pro-
teasome inhibition interferes with
gag polyprotein processing, release,
and maturation of HIV-1 and HIV-
2. Proc. Natl. Acad. Sci. U.S.A. 97,
13057–13062.
Schubert, U., and Strebel, K. (1994).
Differential activities of the human
immunodeﬁciency virus type 1-
encoded Vpu protein are regulated
by phosphorylation and occur in
different cellular compartments. J.
Virol. 68, 2260–2271.
Schulman, B. A., and Harper, J. W.
(2009). Ubiquitin-like protein acti-
vation by E1 enzymes: the apex
fordownstreamsignallingpathways.
Nat.Rev.Mol.CellBiol.10,319–331.
Seago, J., Goodbourn, S., and
Charleston, B. (2010). The classical
swine fever virus Npro product is
degraded by cellular proteasomes
in a manner that does not require
interaction with interferon regu-
l a t o r yf a c t o r3 .J. Gen. Virol. 91,
721–726.
Selvey, L. A., Dunn, L. A., Tindle, R. W.,
Park, D. S., and Frazer, I. H. (1994).
Human papillomavirus (HPV) type
18E7proteinisashort-livedsteroid-
inducible phosphoprotein in HPV-
transformed cell lines. J. Gen. Virol.
75(Pt 7),1647–1653.
Sette, P., Jadwin, J. A., Dussupt, V.,
Bello, N. F., and Bouamr, F. (2010).
The ESCRT-associated protein Alix
recruits the ubiquitin ligase Nedd4-
1 to facilitate HIV-1 release through
theLYPXnLLdomainmotif.J.Virol.
84, 8181–8192.
Shackelford,J.,and Pagano,J. S. (2004).
Tumor viruses and cell signaling
pathways: deubiquitination versus
ubiquitination. Mol. Cell. Biol. 24,
5089–5093.
Shai, A., Pitot, H. C., and Lambert, P.
F. (2010). E6-associated protein is
required for human papillomavirus
type 16 E6 to cause cervical cancer
in mice. Cancer Res. 70, 5064–5073.
Shao, Q., Wang, Y., Hildreth, J. E., and
Liu,B.(2010).Polyubiquitinationof
APOBEC3Gisessentialforitsdegra-
dation by HIV-1 Vif. J. Virol. 84,
4840–4844.
Sharova, N., Wu, Y., Zhu, X., Stran-
ska, R., Kaushik, R., Sharkey, M.,
and Stevenson, M. (2008). Primate
lentiviral Vpx commandeers DDB1
to counteract a macrophage restric-
tion. PLoS Pathog. 4, e1000057. doi:
10.1371/journal.ppat.1000057
Shchelkunov, S. N. (2010). Interaction
of orthopoxviruses with the cellular
ubiquitin-ligase system. Virus Genes
41, 309–318.
Sheehy, A. M., Gaddis, N. C., Choi, J.
D., and Malim, M. H. (2002). Isola-
tion of a human gene that inhibits
HIV-1 infection and is suppressed
by the viral Vif protein. Nature 418,
646–650.
Sheehy,A.M.,Gaddis,N.C.,andMalim,
M. H. (2003). The antiretroviral
enzyme APOBEC3G is degraded by
theproteasomeinresponsetoHIV-1
Vif. Nat. Med. 9, 1404–1407.
Sherry, B. (2009). Rotavirus and
reovirus modulation of the inter-
feronresponse.J.InterferonCytokine
Res. 29, 559–567.
Shi, Y., Xu, P., and Qin, J. (2011).
Ubiquitinated proteome: ready for
global? Mol. Cell. Proteomics 10,
R110.006882.
Shiyanov, P., Nag, A., and Raychaud-
huri, P. (1999). Cullin 4A associates
withtheUV-damagedDNA-binding
protein DDB. J. Biol. Chem. 274,
35309–35312.
Sivachandran, N., Cao, J. Y., and Frap-
pier, L. (2010). Epstein-Barr virus
nuclear antigen 1 hijacks the host
kinase CK2 to disrupt PML nuclear
bodies. J. Virol. 84, 11113–11123.
Sivachandran, N., Sarkari, F., and
Frappier, L. (2008). Epstein-Barr
nuclear antigen 1 contributes to
nasopharyngeal carcinoma through
disruption of PML nuclear bod-
ies. PLoS Pathog. 4, e1000170. doi:
10.1371/journal.ppat.1000170
Skaug, B., Jiang, X., and Chen, Z. J.
(2009). The role of ubiquitin in NF-
kappaB regulatory pathways. Annu.
Rev. Biochem. 78, 769–796.
Sompallae, R., Gastaldello, S., Hilde-
brand, S., Zinin, N., Hassink, G.,
Lindsten, K., Haas, J., Persson, B.,
and Masucci,M. G. (2008). Epstein-
Barr virus encodes three bona ﬁde
ubiquitin-speciﬁc proteases. J. Virol.
82, 10477–10486.
Spann, K. M., Tran, K. C., Chi, B.,
Rabin, R. L., and Collins, P. L.
(2004).Suppressionoftheinduction
of alpha, beta, and lambda inter-
ferons by the NS1 and NS2 pro-
teins of human respiratory syncytial
virus in human epithelial cells and
macrophages [corrected]. J. Virol.
78, 4363–4369.
Spidel, J. L., Craven, R. C., Wilson, C.
B.,Patnaik,A.,Wang,H.,Mansky,L.
M., and Wills, J. W. (2004). Lysines
close to the Rous sarcoma virus late
domain critical for budding. J.Virol.
78, 10606–10616.
Stagg, H. R., Thomas, M., Van Den
Boomen, D., Wiertz, E. J., Drabkin,
H. A., Gemmill, R. M., and Lehner,
P. J. (2009). The TRC8 E3 ligase
ubiquitinatesMHCclassImolecules
before dislocation from the ER. J.
Cell Biol. 186, 685–692.
Stevenson, P. G., Efstathiou, S.,
Doherty, P. C., and Lehner, P.
J. (2000). Inhibition of MHC
class I-restricted antigen presen-
tation by gamma 2-herpesviruses.
Proc. Natl. Acad. Sci. U.S.A. 97,
8455–8460.
Strack, B., Calistri, A., Accola, M. A.,
Palu, G., and Gottlinger, H. G.
(2000). A role for ubiquitin lig-
aserecruitmentinretrovirusrelease.
Proc. Natl. Acad. Sci. U.S.A. 97,
13063–13068.
Straight, S. W., Herman, B., and
Mccance, D. J. (1995). The E5 onco-
protein of human papillomavirus
type 16 inhibits the acidiﬁcation of
endosomes in human keratinocytes.
J. Virol. 69, 3185–3192.
Studamire, B., and Goff, S. P. (2008).
Host proteins interacting with the
Moloney murine leukemia virus
integrase: multiple transcriptional
regulators and chromatin binding
factors. Retrovirology 5, 48.
Tandon, R., Aucoin, D. P., and
Mocarski, E. S. (2009). Human
cytomegalovirus exploits ESCRT
machinery in the process of
virion maturation. J. Virol. 83,
10797–10807.
Teale, A., Campbell, S., van Buuren,
N., Magee, W. C., Watmough, K.,
Couturier, B., Shipclark, R., and
Barry, M. (2009). Orthopoxviruses
require a functional ubiquitin-
proteasome system for pro-
ductive replication. J. Virol. 83,
2099–2108.
Thomas, M., Boname, J. M., Field,
S., Nejentsev, S., Salio, M., Cerun-
dolo, V., Wills, M., and Lehner, P. J.
(2008).Down-regulationofNKG2D
and NKp80 ligands by Kaposi’s
sarcoma-associated herpesvirus K5
protects against NK cell cytotoxic-
ity. Proc. Natl. Acad. Sci. U.S.A. 105,
1656–1661.
Timmins, J., Schoehn, G., Ricard-
Blum, S., Scianimanico, S., Ver-
net, T., Ruigrok, R. W., and Weis-
senhorn, W. (2003). Ebola virus
matrix protein VP40 interaction
with human cellular factors Tsg101
and Nedd4. J. Mol. Biol. 326,
493–502.
Tokarev,A.A.,Munguia,J.,andGuatelli,
J. C. (2010). Serine-threonine ubiq-
uitination mediates downregulation
of BST-2/tetherin and relief of
restricted virion release by HIV-1
Vpu. J. Virol. 85, 51–63.
Tran, K., Mahr, J. A., and Spec-
tor, D. H. (2010). Proteasome
subunits relocalize during human
cytomegalovirus infection, and pro-
teasome activity is necessary for
efﬁcient viral gene transcription. J.
Virol. 84, 3079–3093.
Frontiers in Microbiology | Cellular and Infection Microbiology July 2011 | Volume 2 | Article 161 | 22Gustin et al. Viral takeover of the host ubiquitin system
Ulane, C. M., and Horvath, C. M.
(2002). Paramyxoviruses SV5 and
HPIV2assembleSTATproteinubiq-
uitin ligase complexes from cellular
components.Virology 304,160–166.
Ulane, C. M., Rodriguez, J. J., Parisien,
J. P., and Horvath, C. M. (2003).
STAT3 ubiquitylation and degra-
dation by mumps virus suppress
cytokine and oncogene signaling. J.
Virol. 77, 6385–6393.
Urata, S., Noda, T., Kawaoka, Y.,
Morikawa, S., Yokosawa, H., and
Yasuda, J. (2007). Interaction of
Tsg101 with Marburg virus VP40
depends on the PPPY motif,but not
the PT/SAP motif as in the case
of Ebola virus, and Tsg101 plays
a critical role in the budding of
Marburgvirus-likeparticlesinduced
by VP40, NP, and GP. J. Virol. 81,
4895–4899.
Urata, S., Noda, T., Kawaoka, Y., Yoko-
sawa, H., and Yasuda, J. (2006). Cel-
lular factors required for Lassa virus
budding. J. Virol. 80, 4191–4195.
Urata, S., and Yasuda, J. (2010). Reg-
ulation of Marburg virus (MARV)
buddingbyNedd4.1:adifferentWW
domain of Nedd4.1 is critical for
binding to MARV and Ebola virus
VP40. J. Gen. Virol. 91, 228–234.
Urata, S., Yasuda, J., and De La Torre, J.
C. (2009). The z protein of the new
world arenavirus tacaribe virus has
bona ﬁde budding activity that does
not depend on known late domain
motifs. J. Virol. 83, 12651–12655.
Ushijima, Y., Goshima, F., Kimura, H.,
and Nishiyama, Y. (2009). Herpes
simplex virus type 2 tegument pro-
teinUL56relocalizesubiquitinligase
Nedd4 and has a role in transport
and/or release of virions. Virol. J.
6, 168.
Ushijima, Y., Koshizuka, T., Goshima,
F., Kimura, H., and Nishiyama, Y.
(2008). Herpes simplex virus type 2
UL56 interacts with the ubiquitin
ligase Nedd4 and increases its ubiq-
uitination. J. Virol. 82, 5220–5233.
Van Buuren, N., Couturier, B., Xiong,
Y., and Barry, M. (2008). Ectromelia
virusencodesanovelfamilyofF-box
proteins that interact with the SCF
complex. J. Virol. 82, 9917–9927.
Van Damme, N., Goff, D., Katsura, C.,
Jorgenson, R. L., Mitchell, R., John-
son, M. C., Stephens, E. B., and
Guatelli, J. (2008). The interferon-
induced protein BST-2 restricts
HIV-1 release and is downregulated
from the cell surface by the viral
Vpu protein. Cell Host Microbe 3,
245–252.
Wang, J., Sampath, A., Raychaudhuri,
P., and Bagchi, S. (2001). Both Rb
and E7 are regulated by the ubiq-
uitin proteasome pathway in HPV-
containing cervical tumor cells.
Oncogene 20, 4740–4749.
Wang, X., Connors, R., Harris, M. R.,
Hansen, T. H., and Lybarger, L.
(2005). Requirements for the selec-
tive degradation of endoplasmic
reticulum-resident major histocom-
patibility complex class I proteins by
the viral immune evasion molecule
mK3. J. Virol. 79, 4099–4108.
Wang, X., Herr, R. A., Chua, W. J.,
Lybarger, L., Wiertz, E. J., and
Hansen, T. H. (2007). Ubiquitina-
tion of serine, threonine, or lysine
residues on the cytoplasmic tail can
induce ERAD of MHC-I by viral
E3 ligase mK3. J. Cell Biol. 177,
613–624.
Wang, Y., Shao, Q., Yu, X., Kong, W.,
Hildreth,J.E.,andLiu,B.(2011).N-
terminal hemagglutinin tag renders
lysine-deﬁcient APOBEC3G resis-
tant to HIV-1 Vif-induced degrada-
tion by reduced polyubiquitination.
J. Virol. 85, 4510–4519.
Wang, Y. E., Park, A., Lake, M., Pente-
cost, M., Torres, B., Yun, T. E., Wolf,
M. C., Holbrook, M. R., Freiberg,A.
N., and Lee, B. (2010). Ubiquitin-
regulated nuclear-cytoplasmic traf-
ﬁcking of the Nipah virus matrix
protein is important for viral bud-
ding. PLoS Pathog. 6, e1001186. doi:
10.1371/journal.ppat.1001186
Watanabe,T.,Sorensen,E.M.,Naito,A.,
Schott, M., Kim, S., and Ahlquist, P.
(2007). Involvement of host cellu-
lar multivesicular body functions in
hepatitisBvirusbudding.Proc.Natl.
Acad. Sci. U.S.A. 104, 10205–10210.
Wei, C., Ni, C., Song, T., Liu, Y., Yang,
X., Zheng, Z., Jia,Y.,Yuan,Y., Guan,
K., Xu, Y., Cheng, X., Zhang, Y.,
Wang, Y., Wen, C., Wu, Q., Shi, W.,
and Zhong, H. (2010). The hepati-
tis B virus X protein disrupts innate
immunity by downregulating mito-
chondrialantiviralsignalingprotein.
J. Immunol. 185, 1158–1168.
Weiss, E. R., Popova, E., Yamanaka,
H., Kim, H. C., Huibregtse, J. M.,
and Gottlinger, H. (2010). Res-
cue of HIV-1 release by targeting
widelydivergentNEDD4-typeubiq-
uitin ligases and isolated catalytic
HECTdomainstoGag.PLoSPathog.
6, e1001107. doi: 10.1371/jour-
nal.ppat.1001107
Welcker,M.,and Clurman,B. E. (2005).
The SV40 large T antigen contains a
decoy phosphodegron that mediates
its interactions with Fbw7/hCdc4. J.
Biol. Chem. 280, 7654–7658.
Widjaja,I.,DeVries,E.,Tscherne,D.M.,
Garcia-Sastre, A., Rottier, P. J., and
De Haan, C. A. (2010). Inhibition
of the ubiquitin-proteasome system
affects inﬂuenza A virus infection
at a postfusion step. J. Virol. 84,
9625–9631.
Wiertz, E. J., Jones, T. R., Sun, L.,
Bogyo, M., Geuze, H. J., and
Ploegh, H. L. (1996a). The human
cytomegalovirusUS11geneproduct
dislocates MHC class I heavy chains
from the endoplasmic reticulum to
the cytosol. Cell 84, 769–779.
Wiertz, E. J., Tortorella, D., Bogyo, M.,
Yu, J., Mothes, W., Jones, T. R.,
Rapoport, T. A., and Ploegh, H. L.
(1996b). Sec61-mediated transfer of
a membrane protein from the endo-
plasmic reticulum to the protea-
some for destruction. Nature 384,
432–438.
Williams, C., Van Den Berg, M.,
Sprenger,R.R.,andDistel,B.(2007).
A conserved cysteine is essential
forPex4p-dependentubiquitination
of the peroxisomal import recep-
tor Pex5p. J. Biol. Chem. 282,
22534–22543.
Wilton,B.A.,Campbell,S.,VanBuuren,
N., Garneau, R., Furukawa, M.,
Xiong, Y., and Barry, M. (2008).
Ectromelia virus BTB/kelch pro-
teins, EVM150 and EVM167, inter-
actwithcullin-3-basedubiquitinlig-
ases. Virology 374, 82–99.
Wodrich, H., Henaff, D., Jammart, B.,
Segura-Morales, C., Seelmeir, S.,
Coux, O., Ruzsics, Z., Wiethoff, C.
M., and Kremer, E. J. (2010). A
capsid-encoded PPxY-motif facili-
tates adenovirus entry. PLoS Pathog.
6, e1000808. doi: 10.1371/jour-
nal.ppat.1000808
Wong, J., Zhang, J., Si, X., Gao, G.,
and Luo, H. (2007). Inhibition
of the extracellular signal-regulated
kinase signaling pathway is corre-
latedwithproteasomeinhibitorsup-
pression of coxsackievirus replica-
tion. Biochem. Biophys. Res. Com-
mun. 358, 903–907.
Xu, P., Duong, D. M., Seyfried, N.
T., Cheng, D., Xie, Y., Robert, J.,
Rush, J., Hochstrasser, M., Finley,
D.,and Peng,J. (2009). Quantitative
proteomics reveals the function of
unconventional ubiquitin chains in
proteasomal degradation. Cell 137,
133–145.
Yan, Z., Zak, R., Luxton, G. W., Ritchie,
T. C., Bantel-Schaal, U., and Engel-
hardt, J. F. (2002). Ubiquitination
of both adeno-associated virus type
2 and 5 capsid proteins affects the
transduction efﬁciency of recombi-
nant vectors. J.Virol. 76,2043–2053.
Yang, Z., Yan, Z., and Wood, C.
(2008). Kaposi’s sarcoma-associated
herpesvirus transactivator RTA pro-
motes degradation of the repressors
to regulate viral lytic replication. J.
Virol. 82, 3590–3603.
Ye, Y., Shibata, Y., Yun, C., Ron, D.,
and Rapoport, T. A. (2004). A
membrane protein complex medi-
ates retro-translocation from the ER
lumen into the cytosol. Nature 429,
841–847.
Yokota,S.,Okabayashi,T.,Yokosawa,N.,
and Fujii, N. (2008). Measles virus
P protein suppresses Toll-like recep-
tor signal through up-regulation of
ubiquitin-modifying enzyme A20.
FASEB J. 22, 74–83.
Yoo, N. K., Pyo, C. W., Kim, Y., Ahn, B.
Y., and Choi, S. Y. (2008). Vaccinia
virus-mediated cell cycle alteration
involvesinactivationof tumoursup-
pressors associated with Brf1 and
TBP. Cell. Microbiol. 10, 583–592.
Yu, G. Y., and Lai, M. M. (2005). The
ubiquitin-proteasome system facili-
tates the transfer of murine coron-
avirus from endosome to cytoplasm
during virus entry. J. Virol. 79, 644–
648.
Yu, X., Yu, Y., Liu, B., Luo, K., Kong,
W., Mao, P., and Yu, X. F. (2003).
Induction of APOBEC3G ubiquiti-
nationanddegradationbyanHIV-1
Vif-Cul5-SCF complex. Science 302,
1056–1060.
Yu, Y., Wang, S. E., and Hayward, G. S.
(2005). The KSHV immediate-early
transcription factor RTA encodes
ubiquitin E3 ligase activity that tar-
gets IRF7 for proteosome-mediated
degradation. Immunity 22, 59–70.
Yu, Y., Xiao, Z., Ehrlich, E. S., Yu, X.,
andYu,X.F.(2004).Selectiveassem-
bly of HIV-1 Vif-Cul5-ElonginB-
ElonginC E3 ubiquitin ligase com-
plex through a novel SOCS box and
upstream cysteines. Genes Dev. 18,
2867–2872.
Zhadina, M., and Bieniasz, P. D.
(2010). Functional interchangeabil-
ity of late domains, late domain
cofactorsandubiquitininviralbud-
ding. PLoS Pathog. 6, e1001153. doi:
10.1371/journal.ppat.1001153
Zhadina, M., Mcclure, M. O., John-
son, M. C., and Bieniasz, P. D.
(2007). Ubiquitin-dependent virus
particle budding without viral pro-
teinubiquitination.Proc.Natl.Acad.
Sci. U.S.A. 104, 20031–20036.
www.frontiersin.org July 2011 | Volume 2 | Article 161 | 23Gustin et al. Viral takeover of the host ubiquitin system
Zhang, B., Srirangam, A., Potter, D.
A., and Roman, A. (2005). HPV16
E5 protein disrupts the c-Cbl-
EGFR interaction and EGFR ubiq-
uitination in human foreskin ker-
atinocytes.Oncogene 24,2585–2588.
Zhang, F., Wilson, S. J., Landford, W.
C.,Virgen, B., Gregory, D., Johnson,
M. C., Munch, J., Kirchhoff, F.,
Bieniasz, P. D., and Hatziioannou,
T. (2009). Nef proteins from simian
immunodeﬁciency viruses are
tetherin antagonists. Cell Host
Microbe 6, 54–67.
Zheng, Y., Ao, Z., Wang, B., Danappa
Jayappa, K., and Yao, X. (2011).
Host protein Ku70 binds and pro-
tectsHIV-1integrasefromproteaso-
mal degradation and is required for
HIV replication. J. Biol. Chem. 286,
17722–17735.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 12 May 2011; accepted: 14 July
2011; published online: 28 July 2011.
Citation: Gustin JK, Moses AV, Früh K
and Douglas JL (2011) Viral takeover
of the host ubiquitin system. Front.
Microbio. 2:161. doi: 10.3389/fmicb.
2011.00161
This article was submitted to Frontiers
in Cellular and Infection Microbiology, a
specialty of Frontiers in Microbiology.
Copyright © 2011 Gustin, Moses, Früh
and Douglas. This is an open-access
article subject to a non-exclusive license
between the authors and Frontiers Media
SA, which permits use, distribution and
reproduction in other forums, provided
the original authors and source are cred-
ited and other Frontiers conditions are
complied with.
Frontiers in Microbiology | Cellular and Infection Microbiology July 2011 | Volume 2 | Article 161 | 24